<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32242</article-id><article-id pub-id-type="doi">10.7554/eLife.32242</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>NECAPs are negative regulators of the AP2 clathrin adaptor complex</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-97824"><name><surname>Beacham</surname><given-names>Gwendolyn M</given-names></name><email>gb388@cornell.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97825"><name><surname>Partlow</surname><given-names>Edward A</given-names></name><email>eap248@cornell.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15026"><name><surname>Lange</surname><given-names>Jeffrey J</given-names></name><email>jjl@stowers.org</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-15034"><name><surname>Hollopeter</surname><given-names>Gunther</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6409-0530</contrib-id><email>gh383@cornell.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Molecular Medicine</institution><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Stowers Institute for Medical Research</institution><addr-line><named-content content-type="city">Kansas City</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1160"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Reviewing Editor</role><aff id="aff3"><institution>Stanford University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>01</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e32242</elocation-id><history><date date-type="received" iso-8601-date="2017-09-25"><day>25</day><month>09</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2018-01-17"><day>17</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Beacham et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Beacham et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-32242-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.03648"/><abstract><object-id pub-id-type="doi">10.7554/eLife.32242.001</object-id><p>Eukaryotic cells internalize transmembrane receptors via clathrin-mediated endocytosis, but it remains unclear how the machinery underpinning this process is regulated. We recently discovered that membrane-associated muniscin proteins such as FCHo and SGIP initiate endocytosis by converting the AP2 clathrin adaptor complex to an open, active conformation that is then phosphorylated (Hollopeter et al., 2014). Here we report that loss of <italic>ncap-1</italic>, the sole <italic>C. elegans</italic> gene encoding an adaptiN Ear-binding Coat-Associated Protein (NECAP), bypasses the requirement for FCHO-1. Biochemical analyses reveal AP2 accumulates in an open, phosphorylated state in <italic>ncap-1</italic> mutant worms, suggesting NECAPs promote the closed, inactive conformation of AP2. Consistent with this model, NECAPs preferentially bind open and phosphorylated forms of AP2 in vitro and localize with constitutively open AP2 mutants in vivo. NECAPs do not associate with phosphorylation-defective AP2 mutants, implying that phosphorylation precedes NECAP recruitment. We propose NECAPs function late in endocytosis to inactivate AP2.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>AP2</kwd><kwd>cell biology</kwd><kwd>clathrin adaptor complex</kwd><kwd>FCHo</kwd><kwd>endocytosis</kwd><kwd>NECAP</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Graduate Research Fellowship DGE-1650441</award-id><principal-award-recipient><name><surname>Beacham</surname><given-names>Gwendolyn M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>Training Grant GM007273-43</award-id><principal-award-recipient><name><surname>Beacham</surname><given-names>Gwendolyn M</given-names></name><name><surname>Partlow</surname><given-names>Edward A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Endocytosis is regulated by a protein family that recycles the AP2 clathrin adaptor by restoring the inactive form of complex.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Eukaryotic cells internalize transmembrane protein cargo, such as laden receptors, by enrobing cargo-containing regions of the plasma membrane with a cytosolic clathrin coat. The GTPase dynamin releases the nascent transport vesicle into the cytosol for subsequent delivery to internal organelles. This fundamental cellular process is called clathrin-mediated endocytosis. The Adaptor Protein 2 (AP2) complex, a heterotetramer of α, β2, µ2, and σ2 subunits (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), actively couples polymerization of the clathrin coat to membrane phospholipids and cargo molecules destined for internalization (<xref ref-type="bibr" rid="bib30">Kirchhausen et al., 2014</xref>). In this manner, AP2 choreographs turnover of the cell surface and entry into the endolysosomal system, yet it remains unclear how this complex is regulated with spatiotemporal precision to maintain appropriate levels of endocytosis.</p><p>AP2 activity is likely regulated at the structural level. Biochemical (<xref ref-type="bibr" rid="bib33">Matsui and Kirchhausen, 1990</xref>; <xref ref-type="bibr" rid="bib37">Rapoport et al., 1997</xref>) and structural data suggest that AP2 adopts at least two functionally distinct conformations (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). In one arrangement, the binding pockets for membrane, cargo, and clathrin are occluded; this orientation is thought to represent a closed, inactive state (<xref ref-type="bibr" rid="bib7">Collins et al., 2002</xref>). Molecular rearrangement of the AP2 subunits exposes these binding sites and results in an open, active complex that presumably coordinates the formation of endocytic pits (<xref ref-type="bibr" rid="bib25">Jackson et al., 2010</xref>; <xref ref-type="bibr" rid="bib27">Kelly et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Kelly et al., 2008</xref>).</p><p>Multiple inputs coordinate the conformational rearrangement of AP2 but recent data suggest that membrane-associated muniscin proteins (<xref ref-type="bibr" rid="bib38">Reider et al., 2009</xref>) allosterically activate the AP2 complex (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Umasankar et al., 2014</xref>). These include SH3-containing GRB2-like protein 3-Interacting Protein (SGIP) (<xref ref-type="bibr" rid="bib50">Uezu et al., 2007</xref>) and Fer/CIP4 Homology domain only (FCHo) proteins (<xref ref-type="bibr" rid="bib21">Henne et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Sakaushi et al., 2007</xref>). In <italic>C. elegans</italic>, loss of the sole muniscin, FCHO-1, causes AP2 to dwell in the inactive state, leading to hindered endocytosis (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Residual endocytosis in <italic>fcho-1</italic> mutants is likely coordinated by additional endocytic components acting in parallel (<xref ref-type="bibr" rid="bib31">Ma et al., 2016</xref>; <xref ref-type="bibr" rid="bib34">Mayers et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Wang et al., 2016</xref>). Gain-of-function mutations in AP2 that selectively destabilize the closed conformation, thereby artificially inducing the open state, can bypass loss of FCHO-1. A conserved region of muniscins called the AP2 activator domain (APA), binds AP2 and is also sufficient to rescue both <italic>fcho-1</italic> mutants (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) and FCHo-deficient tissue culture cells (<xref ref-type="bibr" rid="bib51">Umasankar et al., 2014</xref>).</p><p>Activation of AP2 and subsequent clathrin binding also require additional molecular events, including interactions with PI(4,5)P<sub>2</sub> and cargo (<xref ref-type="bibr" rid="bib13">Ehrlich et al., 2004</xref>; <xref ref-type="bibr" rid="bib25">Jackson et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Kadlecova et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Kelly et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Kelly et al., 2008</xref>). Phosphorylation of the AP2 µ2 subunit by an AP2-Associated Kinase (AAK1) (<xref ref-type="bibr" rid="bib8">Conner and Schmid, 2002</xref>) is also proposed to be required for endocytosis (<xref ref-type="bibr" rid="bib35">Olusanya et al., 2001</xref>; <xref ref-type="bibr" rid="bib39">Ricotta et al., 2002</xref>) and is associated with the open form of AP2 (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Höning et al., 2005</xref>). However, it is not entirely clear whether phosphorylation induces the open state, stabilizes the open state (<xref ref-type="bibr" rid="bib25">Jackson et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Kadlecova et al., 2017</xref>), or marks adaptor complexes that have already been incorporated into clathrin coats (<xref ref-type="bibr" rid="bib9">Conner et al., 2003</xref>; <xref ref-type="bibr" rid="bib24">Jackson et al., 2003</xref>; <xref ref-type="bibr" rid="bib47">Semerdjieva et al., 2008</xref>).</p><p>How then is AP2 inactivated and returned to the cytosol after endocytosis is complete? The heat shock protein Hsc70 (<xref ref-type="bibr" rid="bib5">Chappell et al., 1986</xref>) and its cofactors (<xref ref-type="bibr" rid="bib18">Greener et al., 2000</xref>; <xref ref-type="bibr" rid="bib52">Umeda et al., 2000</xref>; <xref ref-type="bibr" rid="bib53">Ungewickell et al., 1995</xref>) remove clathrin coats from vesicles. Release of AP2 is also thought to depend on Hsc70 (<xref ref-type="bibr" rid="bib20">Hannan et al., 1998</xref>) but appears to require additional factors that stimulate the dephosphorylation of µ2 (<xref ref-type="bibr" rid="bib16">Ghosh and Kornfeld, 2003</xref>) and the conversion of vesicular PI(4,5)P<sub>2</sub> into PI(4)P (<xref ref-type="bibr" rid="bib10">Cremona et al., 1999</xref>; <xref ref-type="bibr" rid="bib47">Semerdjieva et al., 2008</xref>). Whether there are mechanisms to directly restore the inactive, closed conformation of AP2 has been relatively unexplored.</p><p>In this study, we identify adaptiN Ear-binding Coat-Associated Proteins (NECAPs) as AP2 modulators that promote inactivation of the complex. NECAPs were originally identified as endocytic accessory proteins through proteomic analysis of clathrin-coated vesicles (<xref ref-type="bibr" rid="bib55">Wasiak et al., 2002</xref>) and were shown to bind the AP2 α appendage via a C-terminal WXXF motif (<xref ref-type="bibr" rid="bib41">Ritter et al., 2004</xref>; <xref ref-type="bibr" rid="bib43">Ritter et al., 2003</xref>). A conserved N-terminal region of these proteins (the PHear domain) appears to be structurally similar to pleckstrin homology domains and exhibits varying affinity for FxDxF motif-containing endocytic accessory proteins (<xref ref-type="bibr" rid="bib40">Ritter et al., 2007</xref>). While most invertebrate and fungal genomes encode a single NECAP, vertebrates express two closely-related forms (<xref ref-type="bibr" rid="bib12">Dergai et al., 2016</xref>; <xref ref-type="bibr" rid="bib32">Manna et al., 2015</xref>) that are thought to be functionally distinct. Brain-enriched NECAP1 is proposed to modulate the size and number of endocytic structures by regulating the binding of clathrin to the AP2 β2 linker and the coordination of accessory protein recruitment to the α appendage (<xref ref-type="bibr" rid="bib42">Ritter et al., 2013</xref>). In support of this model, NECAP1 has been localized to clathrin-coated pits at the ultrastructural level (<xref ref-type="bibr" rid="bib48">Sochacki et al., 2017</xref>). By contrast, ubiquitously-expressed NECAP2 has been proposed to recruit a different clathrin adaptor, AP1, to early endosomes to facilitate fast recycling of receptors back to the cell surface (<xref ref-type="bibr" rid="bib4">Chamberland et al., 2016</xref>).</p><p>Using an unbiased genetic screen in <italic>C. elegans</italic>, we have unveiled a novel role for NECAPs as proteins that work in opposition of muniscins. We demonstrate that in worms lacking NECAPs (<italic>ncap-1</italic> mutants), AP2 accumulates in an open, hyper-phosphorylated state and that heterologous NECAPs restore the closed conformation. NECAPs bind open and phosphorylated forms of the AP2 core but not phosphorylation-defective AP2 mutants, suggesting that NECAPs target the active complex. Together, our genetic and biochemical evidence establish NECAPs as negative regulators of AP2.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Loss of <italic>ncap-1</italic> suppresses <italic>fcho-1</italic> mutants</title><p>By mutagenizing worms lacking <italic>fcho-1</italic> and selecting for offspring that outcompete their siblings (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>), we isolated nine independent loss-of-function mutations in <italic>ncap-1,</italic> which encodes the sole adaptiN Ear-binding Coat-Associated Protein (NECAP) in <italic>C. elegans</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Worms with null mutations in <italic>fcho-1</italic> exhibit reduced fitness and require twice as long as wild type worms to populate a culture plate and consume the bacterial food source. Additionally, they display a distinctive ‘jowls’ phenotype that is indicative of compromised AP2 activity (<xref ref-type="bibr" rid="bib19">Gu et al., 2013</xref>; <xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Loss of NCAP-1 suppressed the jowls phenotype (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and ameliorated the fitness of <italic>fcho-1</italic> mutants (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Expression of fluorescently-tagged NCAP-1 in <italic>fcho-1 ncap-1</italic> double mutants restored the <italic>fcho-1</italic> phenotype (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>), confirming that suppression of <italic>fcho-1</italic> is due to loss of NCAP-1 function.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.002</object-id><label>Figure 1.</label><caption><title>Loss of NCAP-1 suppresses <italic>fcho-1</italic> mutants.</title><p>(<bold>A</bold>) Gene model of the <italic>C. elegans ncap-1</italic> locus. Boxes represent exons. Mutations isolated from the <italic>fcho-1</italic> suppressor screen are indicated. The deletion allele, <italic>mew39</italic>, was used throughout this study as <italic>ncap-1</italic>. The neighboring gene (Y110A2AR.1) is predicted to encode a receptor expression-enhancing protein (REEP). (<bold>B</bold>) Animal heads showing jowls phenotype (red arrows). Anterior is up. WT, wild type; RFP:NCAP-1, red fluorescent protein-tagged NCAP-1 single-copy transgene. (<bold>C</bold>) Starvation assay. Data represent days required for worms to reproduce and consume bacterial food source (top schematic). Bars indicate mean ±SEM for n = 10 biological replicates.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.32242.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>AP2 structures and mutations.</title><p>(<bold>A</bold>) AP2 is comprised of two large adaptins (α and β2) and two smaller subunits (µ2 and σ2). The adaptins, in turn, are comprised of appendage (ear), hinge (linker) and trunk domains. Phosphorylation site and binding pockets are diagrammed. (<bold>B</bold>) Cartoon representations of the closed (<xref ref-type="bibr" rid="bib7">Collins et al., 2002</xref>) and open (<xref ref-type="bibr" rid="bib25">Jackson et al., 2010</xref> and <xref ref-type="bibr" rid="bib27">Kelly et al., 2014</xref>) AP2 conformations. The core complex (dashed line) lacks ears and linkers. (<bold>C</bold>) Table of AP2 mutations used in this study.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig1-figsupp1-v2"/></fig></fig-group><p>Previously we observed that suppression of <italic>fcho-1</italic> correlates with recovery of AP2 activity (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). To evaluate if loss of NCAP-1 also increases AP2 activity in <italic>fcho-1</italic> mutants, we imaged GFP-tagged AP2 α adaptin (APA-2:GFP) in macrophagic cells called coelomocytes that exhibit robust levels of endocytosis (<xref ref-type="bibr" rid="bib45">Sato et al., 2014</xref>). Muniscins, such as FCHO-1, stabilize AP2 on the plasma membrane to promote its incorporation into presumptive pits, or clusters (<xref ref-type="bibr" rid="bib6">Cocucci et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">Henne et al., 2010</xref>; <xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). We performed Fluorescence Recovery After Photobleaching (FRAP) to quantify AP2 stability on the coelomocyte membrane. In the <italic>fcho-1</italic> mutants, fluorescent AP2 recovers approximately three times faster than in wild type worms, indicating that AP2 association with the membrane is destabilized (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Loss of NCAP-1 slowed AP2 kinetics in <italic>fcho-1</italic> animals (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), suggesting that AP2 is incorporated into longer-lived structures. Indeed, we observed improved AP2 clustering in some cells, but the trend was not significant (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Endocytosis of an AP2-dependent model cargo is compromised in <italic>fcho-1</italic> mutants (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) whereas cargo internalization was partially rescued in <italic>fcho-1 ncap-1</italic> worms (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These data indicate that a loss of NCAP-1 improves AP2 activity in <italic>fcho-1</italic> mutants.</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.004</object-id><label>Figure 2.</label><caption><title>Loss of NCAP-1 restores AP2 activity in <italic>fcho-1</italic> mutants.</title><p>(<bold>A</bold>) FRAP analysis of GFP-tagged AP2 α adaptin (APA-2:GFP) on membranes of coelomocytes (top schematic). Time constants (tau) of the fluorescence recovery are plotted. (<bold>B</bold>) AP2 localization in coelomocytes. Representative confocal images of coelomocytes in worms expressing APA-2:GFP. Micrographs (top) are representative maximum projections of Z-slices through approximately half of a cell. Data represent the coefficient of variance (%CV) of pixel intensities for individual cells. (<bold>C</bold>) Artificial AP2 cargo assay. Representative confocal micrographs of intestinal cells (middle) in worms expressing a GFP-tagged cargo (top schematic). TM, transmembrane domain. The average pixel intensity along a basolateral membrane was measured (bottom). (<bold>A–C</bold>) Bars indicate mean ±SEM for n ≥ 8 biological replicates. *p&lt;0.05, **p&lt;0.001, not significant (n.s.), unpaired, two-tailed T-test. (<bold>D</bold>) µ2 protease-sensitivity assay. Western blot analysis of whole worm lysates was used to quantify the amount of full-length µ2 (anti-HA, 50 kDa) before (pre TEV, bottom blot) and after protease induction (post TEV, top blot). Band intensities were compared to a tubulin loading control and normalized to the <italic>fcho-1</italic>(+) <italic>ncap-1</italic>(+) ratio (values below). (<bold>E</bold>) µ2 phosphorylation assay. Western blot analysis of whole worm lysates to quantify phosphorylated µ2 (top blot) relative to total µ2 subunit (bottom blot). Values indicate band intensity ratios of phospho µ2 compared to total µ2, normalized to the <italic>fcho-1</italic>(+) <italic>ncap-1</italic>(+) ratio (values below). (<bold>D and E</bold>) Blots are representative of ≥3 biological replicates. +, wild type allele; -, deletion allele.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig2-v2"/></fig></sec><sec id="s2-2"><title>Open and phosphorylated AP2 accumulates in <italic>ncap-1</italic> mutants</title><p>We previously discovered that AP2 activity in <italic>fcho-1</italic> mutants is also partially restored by amino acid substitutions that specifically destabilize the closed conformation of the adaptor complex, henceforth referred to as ‘open AP2 mutations’ (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Because loss of NCAP-1 phenotypically mimicked open AP2 mutations, we tested whether AP2 also dwells in the open state in <italic>fcho-1 ncap-1</italic> worms. We evaluated AP2 conformation using an in vivo protease-sensitivity assay (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Briefly, a Tobacco Etch Virus (TEV) protease site was inserted into a surface loop of the µ2 subunit that becomes more exposed when AP2 is opened (<xref ref-type="bibr" rid="bib25">Jackson et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Matsui and Kirchhausen, 1990</xref>). Following induction of TEV protease expression, the ensemble protease-sensitivity of the AP2 complexes is determined using western blot analysis of µ2 in whole worm lysates. In <italic>fcho-1</italic> worms, AP2 dwells in a protease-insensitive, closed state (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) and AP2 was more protease-sensitive (open) in <italic>ncap-1</italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These results explain the phenotypic rescue of <italic>fcho-1</italic> mutants and indicate that AP2 accumulates in an open state in the absence of NCAP-1.</p><p>Phosphorylation of µ2 correlates with open AP2 in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Because loss of NCAP-1 increases AP2 protease-sensitivity, we wondered whether µ2 phosphorylation might also be elevated. We quantified the phosphorylation status of AP2 in vivo by blotting worm lysates with an antibody specific to the phosphorylated threonine in µ2 (T160). Loss of NCAP-1 resulted in T160 phosphorylation levels greater than in wild type worms (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Thus, AP2 adopts a hyper-phosphorylated, open state without the action of NCAP-1.</p></sec><sec id="s2-3"><title>Negative regulation of AP2 is a conserved function of NECAPs</title><p>To determine if the ability to inactivate AP2 is a conserved function of NECAPs in the context of our <italic>C. elegans</italic> system, we expressed heterologous NECAPs as single-copy transgenes in <italic>fcho-1 ncap-1</italic> mutant worms. Mouse NECAP1 and NECAP2, as well as a NECAP from the multicellular fungus, <italic>Sphaerobolus stellatus,</italic> recapitulated the reduced fitness of <italic>fcho-1</italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and caused AP2 to adopt a more closed, protease-insensitive state (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). It appears that NECAPs have retained the ability to negatively regulate AP2, at least in <italic>C. elegans</italic>.</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.005</object-id><label>Figure 3.</label><caption><title>NECAPs restore closed AP2 in <italic>fcho-1 ncap-1</italic> worms.</title><p>RFP-tagged NECAPs were expressed as single copy transgenes in <italic>fcho-1 ncap-1</italic> worms. <italic>Ce</italic>, <italic>C. elegans; Mm</italic>, <italic>M. musculus; Ss</italic>, <italic>Sphaerobolus stellatus</italic> (multicellular fungus). +, wild type allele; -, deletion allele. (<bold>A</bold>) Starvation assay performed as in <xref ref-type="fig" rid="fig1">Figure 1C</xref>. Bars represent mean ±SEM for n ≥ 7 biological replicates. **p&lt;0.001, unpaired, two-tailed T-test. (<bold>B</bold>) µ2 protease-sensitivity assay as in <xref ref-type="fig" rid="fig2">Figure 2D</xref>, except a flag-tagged µ2 subunit was used. Band intensities were compared to a histone loading control and normalized to the <italic>fcho-1</italic>(+) <italic>ncap-1</italic>(+) ratio (values below). Blot is representative of 2 biological replicates.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig3-v2"/></fig></sec><sec id="s2-4"><title>NECAPs bind the open and phosphorylated AP2 core in vitro</title><p>We investigated the possibility that NECAPs negatively regulate AP2 via a direct interaction. Indeed, affinity-tagged NECAPs co-purified endogenous AP2 complexes from HEK293 cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), consistent with previous reports (<xref ref-type="bibr" rid="bib43">Ritter et al., 2003</xref>). NECAPs are thought to bind the AP2 α adaptin appendage domain and the clathrin binding box in the β2 adaptin hinge region via a C-terminal WXXF motif and an N-terminal PHear domain, respectively (<xref ref-type="bibr" rid="bib42">Ritter et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Ritter et al., 2003</xref>). Because the C-terminal WXXF motif is poorly conserved in <italic>C. elegans</italic> NCAP-1 (LLDF) and completely absent from the <italic>S. stellatus</italic> protein (PKRR), it was unclear whether the negative regulation of AP2 by heterologous NECAPs (<xref ref-type="fig" rid="fig3">Figure 3</xref>) was mediated via binding to the α appendage. Instead, we were interested to examine whether NECAPs also bind to the AP2 core (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) because this would offer a direct route to conformational regulation. We purified recombinant vertebrate AP2 cores lacking ears and linkers and tested binding of these cores to recombinant NECAPs from worms and mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Interestingly, NECAPs did not bind unmodified AP2 cores (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.006</object-id><label>Figure 4.</label><caption><title>NECAPs bind the open and phosphorylated AP2 core.</title><p>Pulldown assays using affinity-tagged NECAPs. Proteins were cleaved from the affinity tag (HaloTag), electrophoretically separated and then blotted for AP2 subunits (<bold>A and C</bold>) or SYPRO-stained prior to imaging (<bold>B</bold>). Control, HaloTag alone; NC, NECAP; <italic>Ce</italic>, <italic>C. elegans; Mm</italic>, <italic>M. musculus</italic>. (<bold>A</bold>) Western blot analysis (middle) of samples purified from human cell lysates (top schematic) expressing the indicated NECAP bait (bottom). (<bold>B and C</bold>) In vitro pulldown assays using purified recombinant bait (NECAPs, bottom) and prey (vertebrate AP2 cores, top). Co-expression with the kinase domain from mouse AAK1 (+kinase) generates phosphorylated AP2. Amino acid changes in µ2 are indicated: E302K, constitutively open AP2; T156A, phosphorylation-defective AP2; see also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>. 20% of prey input was analyzed for comparison with 50% of the sample released by the protease. (<bold>A–C</bold>) Band intensities of the α subunit (<bold>A</bold>) or the α trunk (<bold>B and C</bold>) were quantified, background signal subtracted, and values normalized to the HaloTag control (values above). Data are representative of 2 biological (<bold>A</bold>), one technical (<bold>B</bold>), and two technical (<bold>C</bold>) replicates.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig4-v2"/></fig><p>Because open and phosphorylated AP2s accumulate in <italic>ncap-1</italic> mutants, we reasoned that NECAPs might act upon these modified forms of AP2. To test our hypothesis, we introduced a previously-characterized open AP2 mutation in the µ2 subunit (E302K; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) to produce recombinant AP2 cores that dwell in the open state. We also co-expressed AP2 with the kinase domain of AAK1 to purify AP2 cores with phosphorylated µ2(T156) (<xref ref-type="bibr" rid="bib23">Höning et al., 2005</xref>). When these modified complexes were tested in our pulldown assays, we observed that NECAPs bound both open and phosphorylated AP2 (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>). These data suggest that NECAPs associate with the AP2 complex in a conformation-dependent manner.</p></sec><sec id="s2-5"><title>NCAP-1 localizes with constitutively open AP2 in vivo</title><p>To corroborate our in vitro pulldown results we sought in vivo evidence that NECAPs associate with open and phosphorylated AP2. In <italic>C. elegans</italic>, fluorescently-tagged AP2 is enriched at the nerve ring, a major neuropil of bundled axons encircling the pharynx (<xref ref-type="bibr" rid="bib56">White et al., 1986</xref>) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We used confocal microscopy to observe localization of NCAP-1 tagged with a red fluorescent protein (RFP:NCAP-1) at the nerve ring in live worms. In both wild type and <italic>fcho-1</italic> mutant worms, NCAP-1 was not overtly enriched compared to AP2. The low level of NCAP-1 relative to AP2 may indicate that in worms, NCAP-1 is not stably associated with AP2 on membranes. However, introduction of a mutation in µ2 known to generate hyper-phosphorylated, constitutively open AP2 (E306K; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) enhanced localization of NCAP-1 nearly 2-fold (<xref ref-type="fig" rid="fig5">Figure 5</xref>). In other words, NCAP-1 was abnormally recruited to the nerve ring in the open AP2 mutant suggesting that NECAPs favor association with activated forms of AP2 in vivo. It is possible that the basal level of localization observed in both wild type and <italic>fcho-1</italic> mutants may represent NCAP-1 bound to the AP2 appendages (<xref ref-type="bibr" rid="bib42">Ritter et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Ritter et al., 2003</xref>).</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.007</object-id><label>Figure 5.</label><caption><title>Phosphorylated AP2 recruits NCAP-1 in vivo.</title><p>Representative confocal slices (middle) through the approximate center of the nerve ring of worms (top schematic) expressing RFP:NCAP-1 and APA-2:GFP. RFP to GFP signal intensity at the nerve ring is plotted (bottom). Mutations in µ2 are indicated: E306K and R440S, constitutively open AP2; T160A, phosphorylation-defective AP2; see also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>. Bars indicate mean ±SEM for n ≥ 10 biological replicates. **p&lt;0.001, unpaired, two-tailed T-test. au, arbitrary units; +, wild type allele; -, deletion allele.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig5-v2"/></fig></sec><sec id="s2-6"><title>AP2 phosphorylation site mutations weaken NECAP binding</title><p>We were curious whether phosphorylation of AP2 is a prerequisite for NECAP binding. Interestingly, in <italic>C. elegans</italic>, mutating the phosphorylation site, µ2(T160), to an alanine, isoleucine, proline, or glutamate suppresses <italic>fcho-1</italic> and produces an open complex according to the in vivo protease-sensitivity assay (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). However, when we purified vertebrate AP2 cores containing the phosphorylation site mutation (T156A; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) and tested their ability to bind mouse NECAP2, we observed very little interaction in pulldown assays (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This result suggests that NECAPs do not bind phosphorylation-defective AP2. To determine whether the phosphorylation site mutants also impact NCAP-1 association with AP2 in vivo, we examined the localization of RFP:NCAP-1 in µ2(T160A) mutant worms. Compared to mutants with hyper-phosphorylated AP2 (E306K), the T160A mutants had less NCAP-1 at the nerve ring (<xref ref-type="fig" rid="fig5">Figure 5</xref>). These results are consistent with the model that NCAP-1 associates with AP2 in a phosphorylation-dependent manner.</p><p>The preferential association of NCAP-1 with the hyper-phosphorylated AP2 (E306K) compared to the phosphorylation-defective AP2 (T160A) was not simply due to differences in the extent to which these mutations generate a protease-sensitive, open AP2 complex (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). When the E306K and T160A mutations were both present in the same µ2 subunit, less RFP:NCAP-1 was localized to the nerve ring compared to when the E306K mutation was combined with another open AP2 mutation (R440S; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>) (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). In other words, the effect of the phosphorylation site mutation was dominant, while the two open AP2 mutations were additive, with respect to NCAP-1 association. Thus, phosphorylation site mutations preclude the association of NCAP-1 with open AP2.</p></sec><sec id="s2-7"><title>Missense mutations render NECAPs functionally inactive</title><p>In the <italic>fcho-1</italic> suppressor screen, we isolated two independent missense mutations in the N-terminal PHear domain of NCAP-1: A29D and S84N (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To investigate the mechanism by which these mutations restore AP2 activity, we engineered them de novo into an RFP:NCAP-1 transgene in an otherwise <italic>ncap-1</italic> null background. These modified NECAPs failed to complement <italic>ncap-1</italic> mutants (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), were unable to restore the closed conformation of AP2 in vivo (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), and were not recruited to the nerve ring by open, hyper-phosphorylated AP2 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Importantly, these mutant proteins were not simply unstable; by western blot analysis they appeared to be expressed at levels similar to the wild type version (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We also introduced the homologous mutations into recombinant <italic>M. musculus</italic> NECAP2 constructs to evaluate AP2 binding using purified components. Even though these mutant NECAPs appeared to be stable and retained the ability to bind open AP2 (E302K), they specifically failed to bind the phosphorylated AP2 core (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). The in vitro pulldown assays suggest that the primary reason the NCAP-1 missense mutants are inefficiently recruited to the nerve ring by the open AP2 mutation in vivo may be that the corresponding adaptor complexes are also phosphorylated. Taken together, our results further suggest that the NCAP-1 mutants fail to inactivate AP2 because they are unable to bind the phosphorylated AP2 core.</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.008</object-id><label>Figure 6.</label><caption><title>Missense mutations render NCAP-1 stable but functionally inactive.</title><p>Amino acid changes isolated from the <italic>fcho-1</italic> suppressor screen (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) were introduced into an RFP-tagged NCAP-1 transgene in <italic>fcho-1 ncap-1</italic> worms. +, wild type allele; -, deletion allele. (<bold>A</bold>) Starvation assay performed as in <xref ref-type="fig" rid="fig1">Figure 1C</xref>. Bars represent mean ±SEM for n ≥ 9 biological replicates. **p&lt;0.001, unpaired, two-tailed T-test. (<bold>B</bold>) µ2 protease-sensitivity assay as in <xref ref-type="fig" rid="fig3">Figure 3B</xref>. (<bold>C</bold>) Western blot analysis to detect HA epitope on NCAP-1 transgenic proteins. (<bold>B and C</bold>) Band intensities were compared to a beta actin loading control and normalized to the <italic>fcho-1</italic>(+) <italic>ncap-1</italic>(+) ratio (<bold>B</bold>) or to the transgenic wild type form of NCAP-1 (<bold>C</bold>) (values below). Blots are representative of 2 biological replicates.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig6-v2"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.32242.009</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Missense mutations in NECAPs prevent association with phosphorylated forms of AP2.</title><p>(<bold>A</bold>) Confocal slices of worm nerve rings were acquired and analyzed as for <xref ref-type="fig" rid="fig5">Figure 5</xref>. Amino acid changes in µ2 (E306K, constitutively open AP2; see also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) and in NCAP-1 are indicated. Bars indicate mean ±SEM for n = 10 biological replicates. **p&lt;0.001, unpaired, two-tailed T-test. au, arbitrary units; +, wild type allele; -, deletion allele. (<bold>B</bold>) In vitro pulldown assays were performed as described in <xref ref-type="fig" rid="fig4">Figure 4B</xref>. Missense mutations in <italic>Mm</italic> NECAP2 bait are indicated (below). +, wild type allele. Data are representative of 1 technical replicate. Band intensities of the α trunk were quantified as in <xref ref-type="fig" rid="fig4">Figure 4</xref> (values above).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-32242-fig6-figsupp1-v2"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In <italic>C. elegans</italic>, loss-of-function mutations in <italic>ncap-1</italic> bypass the requirement for FCHO-1 by restoring AP2 activity and promoting the accumulation of the open, phosphorylated form of AP2. These initial results were consistent with two distinct models: (1) NCAP-1 maintains the closed conformation of AP2 until FCHO-1 releases this inhibition, or (2) NCAP-1 generates the closed conformation of AP2, either directly or indirectly. As a consequence, the inactive form of AP2 predominates in the absence of allosteric activation by FCHO-1. Our subsequent biochemical and imaging data are most consistent with the latter model; NECAP homologs from a variety of organisms bind the open, phosphorylated AP2 core in vitro and restore the closed form of the complex in vivo. We also observe increased recruitment of fluorescently-tagged NCAP-1 by open, hyper-phosphorylated forms of AP2 in vivo. We propose that NECAPs act downstream of muniscin function and µ2 phosphorylation to inactivate AP2 (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.32242.010</object-id><label>Figure 7.</label><caption><title>Model of AP2 activation and inactivation.</title><p>Muniscins allosterically activate AP2 to form a stable association with the membrane. Open AP2 is then phosphorylated on the µ2 subunit by the AP2-associated kinase. NECAPs subsequently bind to open, phosphorylated AP2 and recycle the complex. Generation of the closed form of AP2 presumably involves dephosphorylation and disengagement from the membrane. In the absence of muniscins, AP2 activation is greatly reduced. The <italic>fcho-1</italic> suppressor screen isolated three classes of mutations that enable AP2 to remain active in lieu of muniscins (bottom). Each class disrupts the AP2 inactivation pathway and promotes accumulation of AP2 at discrete steps in the cycle (gray arrows).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-32242-fig7-v2"/></fig><sec id="s3-1"><title><italic>fcho-1</italic> suppressors disrupt the AP2 inactivation pathway</title><p>In the absence of FCHO-1, nematodes exhibit reduced fitness and AP2 dwells in a closed, hypo-phosphorylated state. Using an unbiased genetic screen, we isolated mutations that independently improve the fitness of <italic>fcho-1</italic> genetic nulls. We now recognize that these <italic>fcho-1</italic> suppressors occur in three distinct classes: dominant missense mutations that disrupt the closed conformation of AP2 (class 1) or mutate the phosphorylation site on µ2 (class 2), and recessive mutations that inactivate NCAP-1 (class 3) (<xref ref-type="fig" rid="fig7">Figure 7</xref>). These three classes of mutations appear to rescue <italic>fcho-1</italic> by restoring AP2 activity, but we propose that they achieve this through different mechanisms. Previously, the open AP2 mutants (class 1) appeared to behave similarly to the phosphorylation site mutants (class 2) (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). However, this study reveals that NECAPs clearly distinguish between these two classes. Open, hyper-phosphorylated AP2 mutants (class 1) appear to recruit NECAPs in excess but must be somewhat resistant to their action in order to sustain AP2 activity in the absence of muniscins. By contrast, phosphorylation site mutants (class 2) appear to bypass the requirement for FCHO-1 by evading NECAP binding altogether. Similar to class 2, mutations that directly disrupt NCAP-1 (class 3) probably enable a basal level of AP2 activity to be sustained by complexes that succeed in attaining the open, phosphorylated state in lieu of allosteric activation by muniscins. Importantly, our data suggest that all three classes of suppressors bypass FCHO-1 by disrupting the process by which AP2 closes. The wealth of mutations in AP2 and NECAP identified in the <italic>fcho-1</italic> suppressor screen, combined with our biochemical and imaging data, reveal discrete steps of AP2 conformational and phosphorylation changes during its recycling (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><p>It is curious that the unnaturally active forms of AP2 isolated from our <italic>fcho-1</italic> suppressor screen do not exhibit enhanced endocytosis or membrane association when the <italic>fcho-1</italic> gene is intact (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In other words, why is there not a functional consequence associated with hyperactive AP2 in an otherwise wild type background? Perhaps there are compensatory mechanisms that prevent rampant endocytosis or, alternatively, our assays may lack the sensitivity and range necessary to detect the differences. Indeed, endocytic pits become enlarged after knockdown of NECAP1 and these structures could be a consequence of overactive AP2 (<xref ref-type="bibr" rid="bib42">Ritter et al., 2013</xref>). Although vesicle size was not examined in this paper, regulating the time during which AP2 is phosphorylated and open could directly impact the size of the vesicle that gets internalized.</p></sec><sec id="s3-2"><title>AP2 phosphorylation modulates NECAP recruitment</title><p>NECAPs form stable complexes in vitro with open and phosphorylated AP2 cores, suggesting that activated AP2 may be the endogenous substrate of NECAPs. Indeed, imaging data suggest NECAP dynamics during endocytic pit formation mimic those of clathrin (<xref ref-type="bibr" rid="bib49">Taylor et al., 2011</xref>), consistent with our model that AP2 activation precedes NECAP recruitment. The accumulation of phosphorylated AP2 in the absence of NCAP-1 indicates that phosphorylation may also precede NECAP recruitment but is it unclear whether the phospho-threonine is an essential feature of the NECAP-AP2 interface. Although changing the threonine to a phosphorylation-defective alanine does appear to disrupt the association of NECAPs with AP2 (<xref ref-type="fig" rid="fig4">Figures 4C</xref> and <xref ref-type="fig" rid="fig5">5</xref>), we have not excluded the possibility that this mutation simply precludes NECAP binding by altering the conformation of AP2. Indeed, we observe that NECAPs bind open AP2 cores that have not been phosphorylated (the E302K cores, <xref ref-type="fig" rid="fig4">Figure 4B</xref>) supporting the model that NECAPs bind to a face of active AP2 that does not include the phosphorylated threonine. However, an interaction with these constitutively open, non-phosphorylated cores in vitro may not be relevant; functionally inactive NECAPs (the A29D and S84N mutants) appear to bind these cores in vitro (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>), but do not associate with the equivalent, albeit hyper-phosphorylated, open AP2 mutation in vivo (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). The non-phosphorylated open AP2 core may not be a physiological state of AP2 and might not accurately simulate the in vivo interaction between NECAP and AP2.</p></sec><sec id="s3-3"><title>The core function of NECAPs</title><p>While NECAPs are widely conserved across eukaryotic organisms (<xref ref-type="bibr" rid="bib12">Dergai et al., 2016</xref>), the precise function of this protein family has remained enigmatic. Vertebrate NECAPs exhibit different tissue distributions and are proposed to function in mutually exclusive pathways. For example, NECAP2 was recently shown to regulate AP1 instead of AP2 (<xref ref-type="bibr" rid="bib4">Chamberland et al., 2016</xref>). Despite this proposed divergence, both vertebrate NECAPs rescue loss of NCAP-1 in the nematode, as does a fungal NECAP that lacks the C-terminal α adaptin-ear binding WXXF motif. These results indicate that the capacity to negatively regulate AP2 has been conserved among NECAPs. Based on the missense mutations that disrupt NECAP activity in vivo and AP2 binding in vitro (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), we believe this inhibitory function may involve a direct interaction of the N-terminal PHear domain (<xref ref-type="bibr" rid="bib40">Ritter et al., 2007</xref>) with the phosphorylated AP2 core.</p><p>How do NECAPs sustain the AP2 cycle? We propose the following model (<xref ref-type="fig" rid="fig7">Figure 7</xref>): muniscins such as FCHO-1 promote the open state of AP2, which is phosphorylated on the µ2 subunit by the AP2-associated kinase. NECAPs then bind the AP2 core to counteract the open state, presumably by facilitating a conformational change or dephosphorylation event later in endocytosis. This recycles AP2 back to its inactive state in the cytosol and renders the complex available for another round of endocytosis.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) <break/>or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">gene (<italic>Caenorhabditis</italic> <break/><italic>elegans</italic>)</td><td valign="top"><italic>ncap-1</italic></td><td valign="top">NA</td><td valign="top">CELE_Y110A2AR.3</td><td valign="top"/></tr><tr><td valign="top">gene (<italic>C. elegans</italic>)</td><td valign="top"><italic>fcho-1</italic></td><td valign="top">NA</td><td valign="top">CELE_F56D12.6</td><td valign="top"/></tr><tr><td valign="top">gene (<italic>C. elegans</italic>)</td><td valign="top"><italic>apm-2</italic></td><td valign="top">NA</td><td valign="top">CEAP50, apm-2, <break/>CELE_R160.1</td><td valign="top"/></tr><tr><td valign="top">gene (<italic>C. elegans</italic>)</td><td valign="top"><italic>apa-2</italic></td><td valign="top">NA</td><td valign="top">apt-4, CELE_T20B5.1</td><td valign="top"/></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">N2</td><td valign="top">NA</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/WB-STRAIN:N2_(ancestral)">WB-STRAIN:N2_(ancestral)</ext-link>)</td><td valign="top">Wild type</td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN109</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew31[splice donor]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN110</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew32[A29D]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN111</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew33[S84N]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN112</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew34[splice donor]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN113</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew35[splice donor]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN114</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew36[Q107X]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN115</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew37[splice donor]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN116</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew38[stop lost]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN101</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG6353</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II;</italic> <break/><italic>unc-119(ed3) III</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN86</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>ncap-1(mew39[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN59</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II mewSi2</italic> <break/><italic>[Pdpy-30::RFP:NCAP1 unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8012</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>oxSi254[Pdpy-30::APA-2::GFP</italic> <break/><italic>unc-119(+)] II; unc-119(ed3) III</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG6650</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II oxSi254</italic> <break/><italic>[Pdpy-30::APA-2::GFP unc-119(+)] II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN98</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II oxSi254</italic> <break/><italic>[Pdpy-30::APA-2::GFP unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN97</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>oxSi254[Pdpy-30::APA-2::GFP</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8578</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>oxSi484[Pvha-6::GFP:CD4:YASV</italic> <break/><italic>unc-119(+)] II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8579</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi484[Pvha-6::GFP:CD4:YASV</italic> <break/><italic>unc-119(+)] II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN65</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi484[Pvha-6::GFP:CD4:YASV</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN66</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>oxSi484[Pvha-6::GFP:CD4:YASV</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II;</italic> <break/><italic>apm-2(ox546[W64X]) X oxSi876</italic> <break/><italic>[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8557</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>oxSi883[Phsp-16.41::TEV(protease)</italic> <break/><italic>unc-119(+)] II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)]</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8558</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEV(protease)</italic> <break/><italic>unc-119(+)] II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN100</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II;</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN99</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8555</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi877[Papm-2::3XFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">EG8556</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi877[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN96</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi877[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN106</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; mewSi3</italic> <break/><italic>[Pdpy-30::RFP:NCAP-1 unc-119(+)] IV;</italic> <break/><italic>apm-2(ox546[W64X]) X oxSi877</italic> <break/><italic>[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN91</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; mewSi15</italic> <break/><italic>[Pdpy-30::RFP:Mm_NECAP1</italic> <break/><italic>unc-119(+)] IV; apm-2(ox546[W64X]) X</italic> <break/> <italic>oxSi877[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN93</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; mewSi8</italic> <break/><italic>[Pdpy-30::RFP:Mm_NECAP2</italic> <break/><italic>unc-119(+)] IV; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi877[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN95</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II; mewSi17</italic> <break/><italic>[Pdpy-30::RFP:Ss_NECAP</italic> <break/><italic>unc-119(+)] IV;</italic> <break/><italic>apm-2(ox546[W64X]) X oxSi877</italic> <break/><italic>[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN60</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[Pdpy-30::APA2:GFP</italic> <break/><italic>unc-119(+)] I; mewSi2[Pdpy-30::</italic> <break/><italic>RFP:NCAP1 unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN61</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[Pdpy-30::APA2:GFP</italic> <break/><italic>unc-119(+)] I; fcho-1(ox477::</italic> <break/><italic>unc-119(+)) II mewSi2[Pdpy-30::</italic> <break/><italic>RFP:NCAP1 unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN62</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[Pdpy-30::APA2:GFP</italic> <break/><italic>unc-119(+)] I; fcho-1(ox477::unc-119(+))</italic> <break/><italic>II mewSi2[Pdpy-30::RFP:NCAP1</italic> <break/><italic>unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II;</italic> <break/><italic>apm-2(ox562[E306K]) X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN53</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[Pdpy-30::APA2:GFP</italic> <break/><italic>unc-119(+)] I; fcho-1(ox477::</italic> <break/><italic>unc-119(+)) II mewSi2[Pdpy-30::</italic> <break/><italic>RFP:NCAP1 unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II;</italic> <break/><italic>apm-2(mew44[T160A]) X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN55</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[Pdpy-30::APA2:GFP</italic> <break/><italic>unc-119(+)] I; fcho-1(ox477::</italic> <break/><italic>unc-119(+)) II mewSi2[Pdpy-30::</italic> <break/><italic>RFP:NCAP1 unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II;</italic> <break/><italic>apm-2(ox562[E306K]+mew46[T160A]*) X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN56</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[Pdpy-30::APA2:GFP</italic> <break/><italic>unc-119(+)] I; fcho-1(ox477::</italic> <break/><italic>unc-119(+)) II mewSi2[Pdpy-30::</italic> <break/><italic>RFP:NCAP1 unc-119(+)] II</italic> <break/><italic>ncap-1(mew39[1.4 kb deletion]) II;</italic> <break/><italic>apm-2(ox562[E306K]+mew47[R440S]*) X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN128</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::cb-unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>Cb_unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II;</italic> <break/><italic>mewSi25[RFP:NCAP-1(A29D)*]</italic> <break/><italic>IV; apm-2(ox546[W64X]) X</italic> <break/><italic>oxSi877[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site Cb_unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN135</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1(ox477::cb-unc-119(+)) II</italic> <break/><italic>oxSi883[Phsp-16.41::TEVprotease</italic> <break/><italic>Cb_unc-119(+)] II ncap-1(mew39</italic> <break/><italic>[1.4 kb deletion]) II;</italic> <break/><italic>mewSi35[RFP:NCAP-1(S84N)*] IV;</italic> <break/><italic>apm-2(ox546[W64X]) X oxSi877</italic> <break/><italic>[Papm-2::3xFLAG:APM-2:</italic> <break/><italic>tev-site Cb_unc-119(+)] X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN127</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[APA2:GFP] I; fcho-1(ox477::</italic> <break/><italic>unc-119(+)) II mewSi24[RFP:</italic> <break/><italic>NCAP1(A29D)*] II ncap-1(mew39[1.4 kb</italic> <break/><italic>deletion]) II; apm-2(ox562[E306K])X</italic></td></tr><tr><td valign="top">strain, strain background <break/>(<italic>C. elegans</italic>, hermaphrodite)</td><td valign="top">GUN122</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mewSi1[APA2:GFP] I; fcho-1(ox477::</italic> <break/><italic>unc-119(+)) II mewSi31[RFP:</italic> <break/><italic>NCAP1(S84N)*] II ncap-1(mew39[1.4 kb</italic> <break/><italic>deletion]) II; apm-2(ox562[E306K])X</italic></td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>fcho-1(ox477::unc-119(+))</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew31[splice donor])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew32[A29D])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew33[S84N])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew34[splice donor])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew35[splice donor])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew36[Q107X])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew37[splice donor])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew38[stop lost])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>ncap-1(mew39[1.4 kb</italic> <break/><italic>deletion])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>fcho-1</italic> suppressor</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi2[Pdpy-30::RFP:NCAP1</italic> <break/><italic>unc-119(+)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated with MosSCI</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi3[Pdpy-30::RFP:NCAP-1</italic> <break/><italic>unc-119(+)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated with MosSCI</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi15[Pdpy-30::RFP:</italic> <break/><italic>Mm_NECAP1 unc-119(+)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated with MosSCI</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi8[Pdpy-30::RFP:</italic> <break/><italic>Mm_NECAP2 unc-119(+)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated with MosSCI</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi17[Pdpy-30::RFP:</italic> <break/><italic>Ss_NECAP unc-119(+)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated with MosSCI</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi254[Pdpy-30::APA-2::</italic> <break/><italic>GFP unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi1[Pdpy-30::</italic> <break/><italic>APA-2::GFP unc-119(+)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated with MosSCI</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi484[Pvha-6::GFP:CD4:</italic> <break/><italic>YASV unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi883[Phsp-16.41::</italic> <break/><italic>TEV(protease) unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi876[Papm-2::HA:APM-2:</italic> <break/><italic>tev-site unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi880[Papm-2::HA:APM-2(E306K)</italic>: <break/><italic>tev-site unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi878[Papm-2::HA:APM-2(T160A)</italic>: <break/><italic>tev-site unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>oxSi877[Papm-2::3xFLAG:</italic> <break/><italic>APM-2:tev-site unc-119(+)]</italic></td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>apm-2(ox562[E306K]</italic> <break/><italic>+mew46[T160A])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mew46</italic>[T160A] generated <break/>by CRISPR</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>apm-2(ox562[E306K]</italic> <break/><italic>+mew47[R440S])</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top"><italic>mew47</italic>[R440S] generated <break/>by CRISPR</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi25[RFP:NCAP-1(A29D]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated by CRISPR</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi35[RFP:NCAP-1(S84N)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated by CRISPR</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi24[RFP:NCAP1(A29D)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated by CRISPR</td></tr><tr><td valign="top">genetic reagent (<italic>C. elegans</italic>)</td><td valign="top"><italic>mewSi31[RFP:NCAP1(S84N)]</italic></td><td valign="top">this paper</td><td valign="top"/><td valign="top">Generated by CRISPR</td></tr><tr><td valign="top">cell line (<italic>Homo</italic> <break/><italic>sapiens</italic>, female)</td><td valign="top">HEK293</td><td valign="top">ATCC</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0045">CVCL_0045</ext-link></td><td valign="top"/></tr><tr><td valign="top">transfected construct <break/>(<italic>H. sapiens)</italic></td><td valign="top">pGH500, in HEK239 cells</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘Tissue <break/>culture pulldowns’</td></tr><tr><td valign="top">transfected construct <break/>(<italic>H. sapiens)</italic></td><td valign="top">pGH501, in HEK239 cells</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘Tissue <break/>culture pulldowns’</td></tr><tr><td valign="top">transfected construct <break/>(<italic>H. sapiens)</italic></td><td valign="top">pGH502, in HEK239 cells</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘Tissue <break/>culture pulldowns’</td></tr><tr><td valign="top">antibody</td><td valign="top">mouse monoclonal <break/>anti-adaptin α</td><td valign="top">BD Biosciences</td><td valign="top">Cat# 610501, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_397867">AB_397867</ext-link></td><td valign="top">(1:500)</td></tr><tr><td valign="top">antibody</td><td valign="top">rabbit polyclonal anti-AP2B1</td><td valign="top">Abcam</td><td valign="top">151961, RRID: <break/><ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2721072">AB_2721072</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">antibody</td><td valign="top">rabbit monoclonal <break/>anti-AP2M1 phospho T156</td><td valign="top">Abcam</td><td valign="top">Cat# 109397, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10866362">AB_10866362</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">antibody</td><td valign="top">rabbit monoclonal anti-AP2S1</td><td valign="top">Abcam</td><td valign="top">Cat# 128950, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11140842">AB_11140842</ext-link></td><td valign="top">(1:4000)</td></tr><tr><td valign="top">antibody</td><td valign="top">mouse monoclonal anti-flag</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# F3165, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_259529">AB_259529</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">antibody</td><td valign="top">mouse monoclonal anti-tubulin</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# T5168, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_477579">AB_477579</ext-link></td><td valign="top">(1:2000)</td></tr><tr><td valign="top">antibody</td><td valign="top">rabbit polyclonal anti-histone H3</td><td valign="top">Abcam</td><td valign="top">Cat# 1791, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_302613">AB_302613</ext-link></td><td valign="top">(1:4000)</td></tr><tr><td valign="top">antibody</td><td valign="top">rabbit polyclonal anti-beta actin</td><td valign="top">Abcam</td><td valign="top">Cat# 8227, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2305186">AB_2305186</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">antibody</td><td valign="top">goat anti-mouse Alexa Fluor 488</td><td valign="top">Life Technologies</td><td valign="top">Cat # A11029, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534088">AB_2534088</ext-link></td><td valign="top">(1:4000)</td></tr><tr><td valign="top">antibody</td><td valign="top">goat anti-rabbit Alexa Fluor 647</td><td valign="top">Life Technologies</td><td valign="top">Cat# A21244, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10562581">AB_10562581</ext-link></td><td valign="top">(1:2000)</td></tr><tr><td valign="top">antibody</td><td valign="top">goat anti-rabbit <break/>StarBright Blue 700</td><td valign="top">BioRad</td><td valign="top">Cat# 12004161, <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2721073">AB_2721073</ext-link></td><td valign="top">(1:5000)</td></tr><tr><td valign="top">antibody</td><td valign="top">goat anti-mouse IRDye 800CW</td><td valign="top">LI-COR</td><td valign="top">Cat# 925–32210, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2687825">AB_2687825</ext-link></td><td valign="top">(1:20000)</td></tr><tr><td valign="top">antibody</td><td valign="top">rat monoclonal anti-HA- <break/>Horseradish <break/>peroxidase (HRP)</td><td valign="top">Roche</td><td valign="top">Cat# 12013819001 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_390917">AB_390917</ext-link></td><td valign="top">(1:500)</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pEP29</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘<italic>C. elegans</italic> <break/>NECAP transgenes’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pEP41</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘<italic>C. elegans</italic> <break/>NECAP transgenes’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pEP58</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘<italic>C. elegans</italic> <break/>NECAP transgenes’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pEP71</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘<italic>C. elegans</italic> <break/>NECAP transgenes’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGH495</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘<italic>C. elegans</italic> <break/>NECAP transgenes’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGH505</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in ‘<italic>C. elegans</italic> <break/>NECAP transgenes’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB19</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant AP2 cores’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB21</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant AP2 cores’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB27</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB28</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB29</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB31</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant AP2 cores’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB81</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pEP82</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant AP2 cores’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB91</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">recombinant DNA reagent</td><td valign="top">pGB94</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">pGH494</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">pGH503</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant NECAPs’</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">pGH504</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Cloning described in <break/>‘Recombinant AP2 cores’</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH678</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CGATAGAGAAGGCTTCAACACAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH679</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AGGTATTCAGACATTTTTC <break/>AAATGAAAATCTAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH680</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CAGTCAAAAAATGC <break/>GATAAAAGTACGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH681</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGACAGGAAATTTC <break/>AATAAATTAGCGATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP366</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AACGGGCGGTAGT <break/>GGAGGCACTGGTATG <break/>GGAGATTACGAGAACGTTTTAATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP367</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TATCACCACTTTGTACAAGAAAGCT <break/>GGGTCTAGAAATCTAATAAA <break/>TTGCCAGACGTCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP407</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GAGGAACGGGCGGTAGTGGAG <break/>GCACTGGTATGGAGGAGAGTG <break/>AGTACGAGTCTGTTCTGT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP408</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TCACCACTTTGTACAAGAAAGC <break/>TGGGTCTAGAACTGG <break/>ACCCAGCCGGTG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP409</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGAGGAACGGGCGGTAGTGG <break/>AGGCACTGGTATGGCGGCA <break/>GAGCTGGAATATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP410</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TCACCACTTTGTACAAGAAA <break/>GCTGGGTCTAAAACTGGA <break/>CCCAGTTAGATGGCTGTG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP391</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ACGTCGTGACTGGGAAAACCC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP392</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCCAGGGTTTTCCCAGTCA <break/>CGACGTTGATCATTGGCA <break/>TGCTGAAATATTC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH526</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ATGGTTGTGTCGAAAGGCGA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH528</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ACCAGTGCCTCCACTACCG <break/>CCCGTTCCTCCTGTGCCACC <break/>TTTGTACAGTTCATCCATTCC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH698</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGGGACAAGTTTGTACAAAA <break/>AAGCAGGCTCAAAAATGG <break/>TTGTGTCGAAAGGCGA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH731</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTGACATTAAAGTC <break/>AAAAGCATCTCCTC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH733</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGGGACAAGTTTGTACAAAA <break/>AAGCAGGCTCAAAAATGGGA <break/>GATTACGAGAACGTTTTAAT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH734</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGGGACCACTTTGTACAAGAA <break/>AGCTGGGTTTAGAAATCTAAT <break/>AAATTGCCAGACGTC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH736</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GAGGAGATGCTTTTGAC <break/>TTTAATGTCAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH738</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCGGTAGTGGAGGCACTG <break/>GTATGGGAGATTACGAG <break/>AACGTTTTAATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1011</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TAGACCCAGCTTTCTTGTA <break/>CAAAGTGGTGATA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1012</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ACCAGTGCCTCCAC <break/>TACCGCCCGTT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH953</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CATGCTTCCGCCGGTACCT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH954</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTTTAAACCCGCTGATCAGCCT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH955</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTGGAGGTACCGGCGGAAG <break/>CATGGGAGATTACGAG <break/>AACGTTTTAATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH956</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCTGATCAGCGGGTTTAAACTT <break/>AGAAATCTAATAAATT <break/>GCCAGACGTCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH957</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTGGAGGTACCGGCGGAA <break/>GCATGGCGGCAGAGCTGGAA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH958</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GATCAGCGGGTTTAAACTT <break/>AAAACTGGACCCAGTTAGATGGC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH959</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTGGAGGTACCGGCGGAA <break/>GCATGGAGGAGAGTGAGTACGAGT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH960</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCTGATCAGCGGGTTTAAA <break/>CTTAGAACTGGACCCAGCCGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP13</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TAATTAACCTAGGCTGCTGCCACC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP17</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AAGAAGGAGATATACATAT <break/>GAAGAAGTTTTTCGACTCCAG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP18</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGCAGCAGCCTAGGTTAATT <break/>ACTGTACATTTGGAACGGGGC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB24</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CGCCGCCAGCCAATCTGCCCA <break/>GCCACCTGGCTGGTGA <break/>TCTGGGACTGTTC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB26</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ATGAATAAGCLCTCCGATCA <break/>TCATATGTATATCTCCTTCTTATA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB27</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCATTTATGAAACCCGCT <break/>GCTAATTAACCTAGGC <break/>TGCTGCCACCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB28</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ATGATCGGAGGCTTATTCATCT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB29</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCAGCGGGTTTCATAAATGCCA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB33</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGGCAGATTGGCTGGCG <break/>GCGAGAAGGCATCAAGTA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB34</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AGCAAGAGTCTGGTGCCGCG <break/>CGGCAGCGGTAAGCAGTC <break/>GATCGCCATTGATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB35</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CTGCTTACCGCTGCCGCG <break/>CGGCACCAGACTCTTGCT <break/>TGTTTCATCAGCTGTG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB47</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TGAGATCCGGCTGC <break/>TAACAAAGCC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB48</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TTTAAGAAGGAGATATACA <break/>TATGGCAGAAATCGGTACTGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB49</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AGTGCATCTCCCGTGATGC <break/>AGAAATCTAATAAATTGCCA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB50</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AGTGCATCTCCCGTGATGC <break/>AAAACTGGACCCAGTTAGATGGC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB51</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AGTGCATCTCCCGTGATGCA <break/>GAACTGGACCCAGCCGGTGC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB52</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TGCATCACGGGAGATGCACT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB53</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTTAGCAGCCGGATCTCAGT <break/>GGTGATGATGGTGATGTTG <break/>AAGCTGCCACAAGGCAGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB174</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AGTGCATCTCCCGTGATGC <break/>AGCTTCCGCCGGTACCTCCAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH338</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top">CATATGTATATCTCCTTCTT <break/>ATACTTAACTAATATAC <break/>TAAGATG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP642</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CCGATATCCACGGT <break/>TGGTGGCCCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP643</td><td valign="top">this paper</td><td valign="top"/><td valign="top">ACCAACCGTGGATATCGGG <break/>ACTCAGAATGGCAACT <break/>GGACCAGC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP644</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TCTAGATACTTCGTCATC <break/>CGAATTGAAGATGGA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP645</td><td valign="top">this paper</td><td valign="top"/><td valign="top">AATTCGGATGACGAAGT <break/>ATCTAGAGTTGTCTGT <break/>CACACTCTCCACTGCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH847</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CCAAACTGAAGGTCAAGGTGGTC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH848</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CCTTGACCTTCAGTTTGGTGCGC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH853</td><td valign="top">DOI: 10.7554/eLife.03648</td><td valign="top"/><td valign="top">TAATTAACCTAGGC <break/>TGCTGCCACCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1204</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTTAATTAAAACAG <break/>ATGCACGACGGTT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1205</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTGCATCTGTTTTAATTAACA <break/>TGGAGGAGAGTGAGTACGAGT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1206</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCAGCAGCCTAGGTTAATTA <break/>GAACTGGACCCAGCCGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1227</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGAAGTTCTGTTCCAGG <break/>GGCCCGGGTCCGG <break/>CATGTCCCCT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1228</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCCCCTGGAACAGAACTTC <break/>CAGGCCGGATCCGCCCTTCTT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1231</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CATATGTATATCTCCTT <break/>CTTAAAGTTAAAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1246</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CCGCTGAGCAATAACT <break/>AGCATAAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1247</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CTAATGCAGGAGTCGCATAAGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1249</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GTTATGCTAGTTAT <break/>TGCTCAGCGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGH1250</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TTATGCGACTCCTGCATTAG <break/>GCGCGAGGCAGGATCTCG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">rEP360</td><td valign="top">this paper</td><td valign="top"/><td valign="top">Gene-specific target of crRNA: <break/>TGAAGTGTCTCGTAACAAGA</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">rGB156</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><underline>Gene-specific target of crRNA:</underline> <break/>CAAATCACGTCTCAAGTGAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">rGB155</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><underline>Gene-specific target of crRNA:</underline> <break/>TTGGGTGAAGTTCTAGCATC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">rEP254</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><underline>Gene-specific target of crRNA:</underline> <break/>CGGGCTGTCGAGGTTCCAGT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">rEP676</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><underline>Gene-specific target of crRNA:</underline> <break/>CACAAAATATCGAGAACTAT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">rEP700</td><td valign="top">this paper</td><td valign="top"/><td valign="top"><underline>Gene-specific target of crRNA:</underline> <break/>CCCTGGCAACGCAATTGAGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB154</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TCCCATTGGTTCGcGAAGTGTCT <break/>CGTAACAAGATGaAAGTTAA <break/>GGTATTTCACTTGTCAC</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB159</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TTCGTTACATTGGAcGATCG <break/>GGACTGTATGAAACtAGcTGC <break/>TAGAACTTCACCCAACCCT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oGB130</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GGAGCAGTCACAAATCACGT <break/>CTCAAGTtGCCGGCCAAATT <break/>GGATGGCGTCGGGAGGGTAT</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP674</td><td valign="top">this paper</td><td valign="top"/><td valign="top">TTCGCTATAAAATCCCTATTT <break/>TTCAGAGatGCgGACTGGAAC <break/>CTCGACAGCCCGGCTTGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP680</td><td valign="top">this paper</td><td valign="top"/><td valign="top">CCGCCGATCGGAACCAGCGG <break/>TCATAAAGatGCgGACTGGA <break/>ACCTCGACAGCCCGGCTTGG</td></tr><tr><td valign="top">sequence-based reagent</td><td valign="top">oEP701</td><td valign="top">this paper</td><td valign="top"/><td valign="top">GCCCGATCGATGCGCACCC <break/>TGGCAACGCAATTGAGGCcG <break/>TTTCgGATaacTCTaGATATTT <break/>TGTGATTCGTTTGCAG</td></tr><tr><td valign="top">peptide, recombinant <break/>protein</td><td valign="top">AcTEV Protease</td><td valign="top">Invitrogen</td><td valign="top">12575015</td><td valign="top"/></tr><tr><td valign="top">software, algorithm</td><td valign="top">GraphPad Prism <break/>(version 7.0 c for Mac)</td><td valign="top">GraphPad Software, <break/><ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">www.graphpad.com</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">software, algorithm</td><td valign="top">Fiji</td><td valign="top">doi:10.1038/ <break/>nmeth.2019</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="top"/></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>allele generated by CRISPR</p></fn></table-wrap-foot></table-wrap><sec id="s4-1"><title>Strains</title><p><italic>C. elegans</italic> were maintained using standard procedures (<xref ref-type="bibr" rid="bib3">Brenner, 1974</xref>) on nematode growth medium (NGM) plates seeded with <italic>E. coli</italic> (OP50). For a complete list of strains, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>.</p></sec><sec id="s4-2"><title>Data analysis</title><p>Unpaired, parametric, two-tailed T-tests were performed using GraphPad Prism (version 7.0 c for Mac, GraphPad Software, La Jolla, CA, USA, <ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">www.graphpad.com</ext-link>).</p></sec><sec id="s4-3"><title>Identification of <italic>ncap-1</italic> mutants</title><p>Our initial mutagenesis of <italic>fcho-1</italic> null animals (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) yielded four recessive suppressors in the same complementation group. Single nucleotide polymorphism mapping (<xref ref-type="bibr" rid="bib11">Davis et al., 2005</xref>) placed them on chromosome II and whole genome sequencing revealed four independent mutations in the <italic>ncap-1</italic> gene (<italic>mew31</italic>, <italic>mew36</italic>, <italic>mew38</italic>, and <italic>mew39</italic>). Additional alleles were identified among subsequent <italic>fcho-1</italic> suppressors by amplifying and sequencing the coding segments of <italic>ncap-1</italic> with primer pairs oGH678-9 and oGH680-1. Strains and oligonucleotides are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-4"><title>Starvation assay</title><p>The starvation assay was performed as previously described (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) except that the assay was performed at 25˚C for <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</p></sec><sec id="s4-5"><title>Preparation of worms for microscopy</title><p>For confocal fluorescence microscopy, worms were mounted on 8–10% agarose pads in 3 µL of a 1:1 mix of a 1 µm polystyrene bead slurry (Polysciences, Warrington, PA) and 2X PBS pH 7.4 (<xref ref-type="bibr" rid="bib29">Kim et al., 2013</xref>). For differential interference contrast microscopy (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), worms were mounted on 5% agarose pads in PBS pH 7.4 with 20 mM sodium azide.</p></sec><sec id="s4-6"><title>AP2 localization and FRAP analysis in coelomocytes</title><p>Worms expressing APA-2:GFP (<italic>oxSi254</italic>) were imaged as previously described (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Strains are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>.</p></sec><sec id="s4-7"><title>Cargo assay</title><p>The cargo assay was performed essentially as previously described (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Worms expressing an artificial cargo (<italic>oxSi484</italic>) were imaged on a Ziess LSM 880 confocal microscope (Biotechnology Resource Center, Cornell University, Ithaca, NY) with a 40x water immersion objective. All strains were imaged in one session with the same laser settings. Images were analyzed in Fiji (<xref ref-type="bibr" rid="bib46">Schindelin et al., 2012</xref>). A user defined line was drawn along the membrane between intestinal segments 2 and 3, or segments 3 and 4, and the average pixel intensity was measured along the line. Strains are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>.</p></sec><sec id="s4-8"><title>TEV protease-sensitivity assay</title><p>The TEV assay was performed essentially as previously described (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Post TEV samples were collected at 5–6 hr following heatshock (34˚C, 1 hr). Each sample represents 100 L4 hermaphrodites lysed in 1X Bolt LDS Sample Buffer (Invitrogen, Carlsbad, CA) containing fresh dithiothreitol (DTT; ~100 mM) by sonication (1 s pulses at 90–95% amplitude for 2–3 min) in a cup horn (Branson Ultrasonics Corporation, Danbury, CT) that was chilled to 4˚C. Samples were heated for 10 min at 70˚C prior to gel electrophoresis. All samples were re-sonicated following the 70˚C denaturation step if any exhibited excessive viscosity. Strains are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>.</p></sec><sec id="s4-9"><title>Western blots and SYPRO staining</title><p>Precast polyacrylamide gels (Bolt 4–12% Bis-Tris, Invtrogen) were used for all SDS PAGE experiments. For western blot analysis, proteins were transferred from gels to PVDF Immobilon membranes (Merck Millipore, Tullagreen, Carrigtwohill, Co. Cork, Ireland) using the Pierce Power Blot Cassette system (Thermo Scientific, Rockford, IL). All blocking and antibody incubations (except anti-HA, see below) occurred in Odyssey Blocking Buffer (LI-COR, Lincoln, NE). Primary antibodies and dilutions included mouse anti-adaptin α (1:500, BD Biosciences, San Jose, CA, 610501), rabbit anti-AP2B1 (1:1000, Abcam, Cambridge, MA, 151961), rabbit anti-AP2M1 phospho T156 (1:1000, Abcam 109397), rabbit anti-AP2S1 (1:4000, Abcam 128950), mouse anti-flag (1:1000, Sigma-Aldrich F3165), mouse anti-tubulin (1:2000, Sigma-Aldrich T5168), rabbit anti-histone H3 (1:4000, Abcam 1791), and rabbit anti-beta actin (1:1000, Abcam, 8227). Secondary antibodies included goat anti-mouse Alexa Fluor 488 (1:4000, Life Technologies, Eugene, OR, A11029), goat anti-rabbit Alexa Fluor 647 (1:2000, Life Technologies, A21244), StarBright Blue 700 goat anti-rabbit (1:5000, BioRad, Hercules, CA, 12004161), and goat anti-mouse IRDye 800CW (1:20000, LI-COR, 925–32210).</p><p>Blots probed with the rat anti-HA-Horseradish peroxidase (HRP) antibody (1:500, Roche, Mannheim, Germany, 12013819001) were blocked in Tris Buffered Saline + 0.01% Tween 20 (TBST) with 5% nonfat dry milk. The antibody was diluted in TBST with 1% milk and incubation occurred at room temperature for 1 hr. SuperSignal West Dura Extended Duration Substrate (Thermo Scientific) was used to detect peroxidase.</p><p>Primary antibody incubations occurred for 1 hr at room temperature or overnight at 4˚C. Secondary antibody incubations occurred at room temperature for 30 min – 1 hr in the dark. TBST was used for all washes. Blots were imaged using Bio-Rad ChemiDoc MP systems and band intensities were quantified using the associated ImageLab software.</p><p>We used SYPRO Ruby Protein Gel stain (Lonza, Rockland, ME) to visualize the in vitro pulldowns in <xref ref-type="fig" rid="fig4">Figure 4B</xref> and in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>. Gels were fixed in 50% methanol/7% acetic acid for 30 min and stained with SYPRO for 4–16 hr at room temperature in the dark with gentle agitation. Gels were then washed 2 × 15 min in 10% methanol/7% acetic acid and then 2 × 5 min in water before imaging on a Bio-Rad ChemiDoc MP system.</p></sec><sec id="s4-10"><title><italic>C. elegans</italic> NECAP transgenes</title><p>We generated <italic>C. elegans</italic> targeting vectors for expression of NECAPs as single-copy transgenes (<xref ref-type="bibr" rid="bib14">Frøkjaer-Jensen et al., 2008</xref>). For <xref ref-type="fig" rid="fig1">Figure 1B and C</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>, and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>, a mini-gene encoding NCAP-1 was constructed using the Multisite Gateway System (Invitrogen). The first 4 exons of the <italic>ncap-1</italic> gene were amplified with primer pair oGH731 + 3, while the other half of the coding sequence was amplified from cDNA using primer pair oGH734 + 6. The two amplicons were recombined using the Gibson assembly reaction (<xref ref-type="bibr" rid="bib17">Gibson et al., 2009</xref>) and then recombined with the [1-2] donor vector using BP clonase (Invitrogen). The entry clone was amplified with oGH698 + 738 and a worm codon-optimized TagRFP-T (Ed Boyden, MIT, Cambridge, MA) was amplified with oGH526 + 8 and inserted upstream of the <italic>ncap-1</italic> coding sequences using Gibson assembly. The resulting [1-2] entry clone (pGH505) was recombined with a [4-1] entry containing the ubiquitous dpy-30 promoter, the unc-54 3’UTR in a [2-3] entry and the [4-3] destination vector pCFJ150 (Christian Frøkjær-Jensen, University of Utah) using LR clonase (Invitrogen) to generate the MosSCI targeting vector (pGH495) that was injected into worm strain EG6699 (<xref ref-type="bibr" rid="bib15">Frøkjær-Jensen et al., 2012</xref>).</p><p>For <xref ref-type="fig" rid="fig3">Figure 3</xref>, the coding sequences of NECAPs were amplified from plasmid templates using the following primers: oEP366-7 for <italic>C. elegans</italic> NCAP-1 (NM_061997.5), oEP409-10 for <italic>M. musculus</italic> NECAP1 (BK000656.1) and oEP407-8 for <italic>M. musculus</italic> NECAP2 (BK000657.1). The coding sequence of NECAP from <italic>Sphaerobolus stellatus</italic> (Cannonball Fungus protein KIJ44287) was synthesized as a gBlock (IDT, Coralville, IA). These DNA fragments were then assembled in a MosSCI targeting vector backbone generated as two amplicons from pGH486 (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>), using primer pairs oGH1011 + oEP392 and oGH1012 + oEP391, in a three-piece Gibson assembly reaction. The plasmids generated were: pEP29 for <italic>C. elegans</italic> NCAP-1, pEP58 for <italic>M. musculus</italic> NECAP1, pEP41 for <italic>M. musculus</italic> NECAP2, and pEP71 for <italic>S. stellatus</italic> NECAP. These included targeting sequences corresponding to the <italic>cxTi10816</italic> locus and were inserted into the genomes of EG6703 worms as described (<xref ref-type="bibr" rid="bib15">Frøkjær-Jensen et al., 2012</xref>). The resulting transgenes drive expression of RFP-tagged NECAPs from a ubiquitous <italic>C. elegans</italic> promoter (<italic>Pdpy-30</italic>). Strains, plasmids, and oligonucleotides are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-11"><title>Tissue culture pulldowns</title><p>The heterologous expression of affinity-tagged proteins in HEK293 cells followed by HaloTag isolation from cell lysates and western blots analysis of the purified proteins was performed as described (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>). Mammalian vectors for the expression of HaloTag fusions with the worm and mouse NECAPs were generated by amplifying the coding sequences from cDNA and inserting them by Gibson assembly into a custom-built HaloTag expression vector (<xref ref-type="bibr" rid="bib2">Banks et al., 2014</xref>) that was amplified using oGH953-4. The <italic>C. elegans</italic> NCAP-1 (NM_061997.5; amplicon oGH955-6) expression vector is pGH500, while the <italic>M. musculus</italic> NECAP1 (BK000656.1; amplicon oGH957-8) is pGH501, and <italic>M. musculus</italic> NECAP2 (BK000657.1; amplicon oGH959-60) is pGH502. Plasmids and oligonucleotides are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary files 1B and 1C</xref>, respectively. The identity of the HEK293 cells was 100% matched by STR Profiling at ATCC. Cells were negative for mycoplasma using ATCC PCR kit #30–1012K on January 10, 2017.</p></sec><sec id="s4-12"><title>Recombinant AP2 cores</title><p>Bicistronic vectors expressing the hexahistidine-tagged mouse AP2 β2 trunk along with mouse µ2 were based on pGH424 (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) and generated as follows: Mutations were introduced in µ2 using Gibson assembly, and primers oGH847-8 for E302K and oGB24 + 33 for T156A. A thrombin protease site (not utilized in this study) was inserted after amino acid 236 of µ2 using oGB34-35. The construct encoding wild type β2 trunk/µ2 is pGB21, while β2 trunk/µ2(E302K) is pGB19 and β2 trunk/µ2(T156A) is pGB31. The bicistronic vector expressing the GST-tagged mouse AP2 α trunk along with rat σ2 (pGH504) was generated as follows: The α trunk/σ2 hemicomplex was amplified from the original expression vector (<xref ref-type="bibr" rid="bib7">Collins et al., 2002</xref>) using primers oGH1249-50 and recombined with the pACYCDuet vector backbone (amplicon oGH1246-47) using Gibson assembly. The thrombin cleavage site between the α trunk and GST was replaced with the human rhinovirus (HRV) C3 protease site (not utilized in this study) with oGH1227-8 and Gibson assembly. Simultaneous expression of all four subunits of the AP2 core was achieved by transforming <italic>E. coli</italic> BL21(DE3) cells (New England Biolabs, Ipswich, MA) with a pair of the bicistronic vectors and co-selecting for ampicillin resistance (pGB21, pGB19 or pGB31) and chloramphenicol resistance (pGH504). To generate phosphorylated AP2 cores, the kinase domain of mouse AAK1 (amino acids 1–325, BC141176.1) was amplified from plasmid template using oEP17-18 and inserted into the pRSFDuet backbone amplified with oEP13 + oGH338 using Gibson assembly. The AP2 subunits were co-expressed with this vector (pEP82) by including selection for kanamycin resistance. Plasmids and oligonucleotides are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary files 1B and 1C</xref>, respectively.</p><p>2xYT culture media containing the appropriate antibiotics was inoculated with an overnight culture of bacterial cells expressing AP2 cores and incubated at 37˚C with shaking at 180–200 RPM until OD<sub>600</sub> = ~1.0. The temperature was decreased to 18˚C for 1 hr before expression was induced with 100 µM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 20–24 hr. Cells were harvested by centrifugation, washed with lysis buffer (see below), and snap frozen in liquid N2 prior to storage at −80˚C. Cell pellets were resuspended in 50 mL lysis buffer per liter of initial culture volume. GST lysis buffer consists of PBS pH 7.4, 1 mM DTT, 60 µg/mL DNase I (grade II from bovine pancreas, Roche), 2.5 mM MgCl<sub>2</sub>, 0.3 mg/mL lysozyme (Sigma), and 1 mM phenylmethylsulfonyl fluoride (PMSF) (Millipore, Billerica, MA) with the addition of 1 tablet of cOmplete EDTA-free Protease Inhibitor Cocktail (Roche) for every 100 mL. The cell slurry was sonicated (20 s pulses at 20% amplitude for a total of 8 min; 50 mL at a time) using a Q700 sonicator (Qsonica, Newtown, CT). Lysates were cleared by centrifugation (~20000 x g) and filtration (0.2 µm). Cleared filtrate was rotated for 1 hr at 4˚C with equilibrated GST resin (GE Healthcare Life Sciences, Uppsala, Sweden), 1 ml resin per liter of the initial culture volume. The filtrate and resin were poured over a gravity column, washed with PBS pH 7.4 + 1 mM DTT, and AP2 was eluted with 50 mM Tris, 150 mM NaCl, 10 mM reduced glutathione, and 1 mM DTT, pH 8.0 (Fischer BioReagents, Fairlawn, NJ). The eluate buffer was exchanged with TBS pH 7.6 + 1 mM DTT and AP2 cores were concentrated to ~0.5 mg/mL using an Amicon Centrifugal Filter Unit with a 100 kDa cutoff (Merck Millipore). Aliquots of AP2 cores were snap frozen in liquid N2 prior to storage at −80˚C.</p></sec><sec id="s4-13"><title>Recombinant NECAPs</title><p>The NECAP used in <xref ref-type="fig" rid="fig4">Figure 4C</xref> had an N-terminal hexahistidine tag, HaloTag and TEV protease site. Mouse NECAP2 (BK000657.1) was amplified from pGH502 using primers oGH1205-6, and recombined with the backbone of the 6xHis-HaloTag-APA expression vector pGH493 (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>) (amplified with oGH853 + 1204) using Gibson assembly. This replaced the APA domain with NECAP2 and generated pGH503.</p><p>Because we sometimes noted heterogeneity in our recombinant NECAPs, we built a set of vectors to purify NECAPs with cleavable C-terminal affinity tags. The NECAPs used for pulldowns in <xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref> were purified using the Intein Mediated Purification with an Affinity Chitin-binding Tag (IMPACT, NEB) system, with slight modifications. The <italic>Mxe</italic> GyrA intein tag and chitin binding domain (CBD) from pTXB1 (NEB) were amplified using oGB52-3 (which adds a hexahistidine tag onto the C-terminus of the CBD). This amplicon was inserted into the pET21b expression vector (PCR product of oGB47 + oGH1231) in a three-piece Gibson reaction along with one of the following NECAPs: pGB29 included <italic>C. elegans</italic> NCAP-1 (NM_061997.5, amplified with oGB48-9 from pGH500), pGB27 included <italic>M. musculus</italic> NECAP1 (BK000656.1, amplified with oGB48 + 50 from pGH501) and pGB28 included <italic>M. musculus</italic> NECAP2 (BK000657.1, amplified with oGB48 + 51 from pGH502). The NECAPs were amplified such that they include the N-terminal HaloTag and TEV protease site from the mammalian expression vectors (see Tissue culture pulldowns). To generate the NECAPs used in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>, mutations were introduced in NECAP2 (pGB28) using Gibson assembly with oEP642-3 (A32D; pGB91) and oEP644-5 (S87N; pGB94). To generate a HaloTag control protein for these pulldowns (pGB81), pGB28 was amplified with oGB52 + 174 and recombined in a one-piece Gibson reaction to remove the NECAP sequence. All plasmids and oligonucleotides are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B and 1C</xref>, respectively.</p><p><italic>E. coli</italic> BL21(DE3) cells (NEB) expressing HaloTag-NECAPs-intein-6xHis (pGB27-9, pGB91, pGB94), 6xHis-HaloTag-NECAP2 (pGH503), the 6xHis-HaloTag control (pGH494) (used in <xref ref-type="fig" rid="fig4">Figure 4B and C</xref>) (<xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref>), or the HaloTag-intein-6xHis control (pGB81) (used in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>) were cultured in Terrific Broth (RPI) containing carbenicillin selection. Cultures were subsequently grown as described for AP2 cores (above) except expression was induced with 300 µM IPTG and cells were harvested after 16–20 hr incubation at 18˚C.</p><p>For 6xHis-HaloTag-NECAP2 (pGH503) and 6xHis-HaloTag (pGH494) cell pellets collected from 500 mL of culture were re-suspended in 50 mL nickel lysis buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 30 mM imidazole, 5% glycerol, 5 mM BME) with the addition of 60–200 µg/mL DNase I (grade II from bovine pancreas, Roche), 2.5 mM MgCl<sub>2</sub>, 1 tablet of cOmplete EDTA-free Protease Inhibitor Cocktail (Roche), 0.3 mg/mL lysozyme (Sigma), and 1 mM PMSF. Cells were lysed by sonication using a Q700 sonicator (Qsonica) at 20% amplitude with 20 s pulses for 4 min total, centrifuged at ~20000 x g for 30 min and filtered to 0.2 µm. The hexahistidine-tagged proteins were purified using nickel-charged 5 mL HiTrap Chelating HP columns (GE Healthcare Life Sciences) on a BioLogic LP system (BioRad). After sample loading, columns were washed with nickel lysis buffer and bound proteins were eluted with nickel elution buffer (nickel lysis buffer with 1 M imidazole). Fractions (1 mL each) containing the protein of interest were combined, buffer exchanged with 20 mM Tris pH 8, 5% glycerol, 1 mM EDTA, 1 mM DTT, and 50 mM NaCl and purified by ion exchange chromatography using a HiTrap Q HP column (GE Healthcare Life Sciences) on the BioLogic LP system (BioRad). After sample loading, proteins were eluted using a salt gradient (50 mM to 1000 mM NaCl). Elution fractions containing the protein of interest were combined and aliquots were snap frozen in liquid N2 prior to storage at −80˚C.</p><p>To purify recombinant NECAPs (HaloTag-NECAPs-intein-6xHis) or the HaloTag-intein-6xHis control we used a modified version of the IMPACT system. Cell lysis was performed as described for other hexahistidine-tagged proteins (above) except BME was omitted from the lysis buffer to inhibit intein self-cleavage. Cleared lysates were loaded onto gravity columns containing nickel resin (Thermo Scientific, 0.5 mL per 500 mL initial culture volume) and washed extensively. Columns were then flushed with nickel lysis buffer containing 40 mM BME, plugged, and incubated at 4˚C for 30 to 40 hr in order to cleave proteins from the intein tag. The released proteins were collected, buffer exchanged with TBS pH 7.6 + 1 mM DTT, and concentrated using an Amicon Centrifugal Filter Unit with 50 kDa MW cutoff (Merck Millipore) or with 30 kD MW cutoff for the HaloTag control. Aliquots were snap frozen in liquid N2 prior to storage at −80˚C.</p></sec><sec id="s4-14"><title>In vitro pulldown assays</title><p>Pulldown assays were performed essentially as described in <xref ref-type="bibr" rid="bib22">Hollopeter et al., 2014</xref> except the protease cleavage step was 3 hr and the input gel sample represented 20% of the ‘prey’ protein mixture.</p></sec><sec id="s4-15"><title>Nerve ring microscopy</title><p>Worms expressing APA-2:GFP (<italic>mewSi1</italic>) and RFP:NCAP-1 (<italic>mewSi2</italic>) in an <italic>ncap-1</italic> background were imaged on an Zeiss LSM 880 confocal microscope (Biotechnology Resource Center) with a 40x water immersion objective. APA-2:GFP(<italic>mewSi1</italic>) is molecularly similar to APA-2:GFP(<italic>oxSi254</italic>) (<xref ref-type="bibr" rid="bib19">Gu et al., 2013</xref>) except the entry clones ([4-1]<italic>Pdpy-30</italic>, [1-2]<italic>apa-2</italic> cDNA, and [2-3]<italic>GFP:unc-54 3’UTR</italic>) were recombined with the [4-3] MosSCI vector (pCFJ210) to target the ttTi4348 site in EG6701 worms (<xref ref-type="bibr" rid="bib15">Frøkjær-Jensen et al., 2012</xref>). Fluorophores were excited with 488 nm (GFP) and 561 nm (RFP) lasers. All strains were imaged in one session with the same laser settings. For each worm, a single confocal slice through the approximate sagittal section of the nerve ring was analyzed in Fiji (<xref ref-type="bibr" rid="bib46">Schindelin et al., 2012</xref>). Two regions of interest (ROI) corresponding to both dorsal and ventral sections of the nerve ring along with an ROI outside of the worm (to control for background signal) were user defined. The average pixel intensities in both the GFP and RFP channels were determined and the background values were subtracted from the nerve ring values.</p></sec><sec id="s4-16"><title>CRISPR-Cas9 generation of µ2 and NCAP-1 mutations</title><p>CRISPR/Cas9 edits were generated using the <italic>dpy-10</italic> co-conversion strategy (<xref ref-type="bibr" rid="bib1">Arribere et al., 2014</xref>) with ribonucleoprotein (RNP) complexes (<xref ref-type="bibr" rid="bib36">Paix et al., 2015</xref>). For generating µ2 mutations, gonads of young adult hermaphrodites were injected with RNP mixes containing ~3.7 µg/µL Cas9 (purified in-house), 1 µg/µL tracrRNA, 0.08 µg/µL <italic>dpy-10</italic> crRNA, 16.7 µM <italic>dpy-10(cn64)</italic> roller repair, 0.4 µg/µL gene-specific crRNA, and 16.7 µM gene-specific repair. The gene-specific crRNAs and oligonucleotide repairs were as follows: to generate µ2(E306K) – rEP360 and oGB154 (introduces an <italic>Nru</italic>I site for genotyping), to generate µ2(T160A) – rGB156 and oGB130 (introduces an <italic>Ngo</italic>MIV site), and to generate µ2(R440S) – rGB155 and oGB159 (introduces a <italic>Pvu</italic>I site). F1 progeny exhibiting the roller phenotype were placed on individual culture plates and allowed to produce offspring for 1–2 days before being lysed in 50 µL 1X Phusion GC buffer (NEB) with 0.4 U Proteinase K (NEB) by freezing at −80˚C and then heating at 65˚C for 1 hr followed by 95˚C for 15 min. The targeted region of the genome was amplified using PCR and the amplicon was digested to identify correctly edited worms. Mutations were confirmed by sequencing the PCR product.</p><p>To generate NCAP-1 missense mutations, injection mixes were prepared with 5 µM of each repair. The gene-specific crRNAs and oligonucleotide repairs were as follows: to generate RFP:NCAP-1(A29D) in the microscopy strain GUN62 – rEP254 and oEP674, to generate RFP:NCAP-1(A29D) in the TEV assay strain GUN106 – rEP254 and oEP680, and to generate RFP:NCAP-1(S84N) – rEP676 + 700 (each at 0.2 µg/µL) and oEP701 (introduces an <italic>Xba</italic>I site).</p><p>All materials and resources described in this article are available upon request with no restrictions.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Erik Jorgensen, Alejandro Sánchez Alvarado, and the Stowers Institute for Medical Research for support. Ho Yi Mak provided lab space, reagents, and technical advice during the early stages of this work at the Stowers Institute. Technical assistance at the Stowers Institute was provided by Jim Vallandingham (Bioinformatics), Kendra Walton (Molecular Biology), and Valerie Neubauer (Tissue Culture). We thank the labs of Maurine Linder, Joshua Chappie, Carolyn Sevier, Hector Aguilar-Carreno, Carrie Adler, and Scott Emr for technical advice, reagents and the use of equipment. We thank Anthony Bretscher, Carolyn Sevier, Chris Fromme, Joshua Chappie, Carrie Adler, and Holger Sondermann for constructive criticism that greatly improved the manuscript. The Zeiss LSM 880 confocal microscope was purchased with Cornell University Biotechnology Resource Center instrument grants NYSTEM CO29155 and NIH S10OD018516. GMB and EAP were supported by an NIH training grant GM007273-43. GMB is supported by an NSF graduate research fellowship DGE-1650441.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Software, Formal analysis, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.32242.011</object-id><label>Supplementary file 1.</label><caption><title>(A) Strains (B) Plasmids (C) Oligonucleotides.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-32242-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.32242.012</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-32242-transrepform-v2.pdf"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arribere</surname> <given-names>JA</given-names></name><name><surname>Bell</surname> <given-names>RT</given-names></name><name><surname>Fu</surname> <given-names>BX</given-names></name><name><surname>Artiles</surname> <given-names>KL</given-names></name><name><surname>Hartman</surname> <given-names>PS</given-names></name><name><surname>Fire</surname> <given-names>AZ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans</article-title><source>Genetics</source><volume>198</volume><fpage>837</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1534/genetics.114.169730</pub-id><pub-id pub-id-type="pmid">25161212</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname> <given-names>CA</given-names></name><name><surname>Lee</surname> <given-names>ZT</given-names></name><name><surname>Boanca</surname> <given-names>G</given-names></name><name><surname>Lakshminarasimhan</surname> <given-names>M</given-names></name><name><surname>Groppe</surname> <given-names>BD</given-names></name><name><surname>Wen</surname> <given-names>Z</given-names></name><name><surname>Hattem</surname> <given-names>GL</given-names></name><name><surname>Seidel</surname> <given-names>CW</given-names></name><name><surname>Florens</surname> <given-names>L</given-names></name><name><surname>Washburn</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Controlling for gene expression changes in transcription factor protein networks</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>13</volume><fpage>1510</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1074/mcp.M113.033902</pub-id><pub-id pub-id-type="pmid">24722732</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>The genetics of <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>77</volume><fpage>71</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">4366476</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberland</surname> <given-names>JP</given-names></name><name><surname>Antonow</surname> <given-names>LT</given-names></name><name><surname>Dias Santos</surname> <given-names>M</given-names></name><name><surname>Ritter</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>NECAP2 controls clathrin coat recruitment to early endosomes for fast endocytic recycling</article-title><source>Journal of Cell Science</source><volume>129</volume><fpage>2625</fpage><lpage>2637</lpage><pub-id pub-id-type="doi">10.1242/jcs.173708</pub-id><pub-id pub-id-type="pmid">27206861</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname> <given-names>TG</given-names></name><name><surname>Welch</surname> <given-names>WJ</given-names></name><name><surname>Schlossman</surname> <given-names>DM</given-names></name><name><surname>Palter</surname> <given-names>KB</given-names></name><name><surname>Schlesinger</surname> <given-names>MJ</given-names></name><name><surname>Rothman</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Uncoating ATPase is a member of the 70 kilodalton family of stress proteins</article-title><source>Cell</source><volume>45</volume><fpage>3</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(86)90532-5</pub-id><pub-id pub-id-type="pmid">2937542</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocucci</surname> <given-names>E</given-names></name><name><surname>Aguet</surname> <given-names>F</given-names></name><name><surname>Boulant</surname> <given-names>S</given-names></name><name><surname>Kirchhausen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The first five seconds in the life of a clathrin-coated pit</article-title><source>Cell</source><volume>150</volume><fpage>495</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.05.047</pub-id><pub-id pub-id-type="pmid">22863004</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>BM</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Kent</surname> <given-names>HM</given-names></name><name><surname>Evans</surname> <given-names>PR</given-names></name><name><surname>Owen</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Molecular architecture and functional model of the endocytic AP2 complex</article-title><source>Cell</source><volume>109</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00735-3</pub-id><pub-id pub-id-type="pmid">12086608</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conner</surname> <given-names>SD</given-names></name><name><surname>Schmid</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis</article-title><source>The Journal of Cell Biology</source><volume>156</volume><fpage>921</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1083/jcb.200108123</pub-id><pub-id pub-id-type="pmid">11877461</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conner</surname> <given-names>SD</given-names></name><name><surname>Schröter</surname> <given-names>T</given-names></name><name><surname>Schmid</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>AAK1-mediated micro2 phosphorylation is stimulated by assembled clathrin</article-title><source>Traffic</source><volume>4</volume><fpage>885</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1046/j.1398-9219.2003.0142.x</pub-id><pub-id pub-id-type="pmid">14617351</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cremona</surname> <given-names>O</given-names></name><name><surname>Di Paolo</surname> <given-names>G</given-names></name><name><surname>Wenk</surname> <given-names>MR</given-names></name><name><surname>Lüthi</surname> <given-names>A</given-names></name><name><surname>Kim</surname> <given-names>WT</given-names></name><name><surname>Takei</surname> <given-names>K</given-names></name><name><surname>Daniell</surname> <given-names>L</given-names></name><name><surname>Nemoto</surname> <given-names>Y</given-names></name><name><surname>Shears</surname> <given-names>SB</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name><name><surname>McCormick</surname> <given-names>DA</given-names></name><name><surname>De Camilli</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Essential role of phosphoinositide metabolism in synaptic vesicle recycling</article-title><source>Cell</source><volume>99</volume><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81649-9</pub-id><pub-id pub-id-type="pmid">10535736</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>MW</given-names></name><name><surname>Hammarlund</surname> <given-names>M</given-names></name><name><surname>Harrach</surname> <given-names>T</given-names></name><name><surname>Hullett</surname> <given-names>P</given-names></name><name><surname>Olsen</surname> <given-names>S</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Rapid single nucleotide polymorphism mapping in <italic>C. elegans</italic></article-title><source>BMC Genomics</source><volume>6</volume><elocation-id>118</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-6-118</pub-id><pub-id pub-id-type="pmid">16156901</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dergai</surname> <given-names>M</given-names></name><name><surname>Iershov</surname> <given-names>A</given-names></name><name><surname>Novokhatska</surname> <given-names>O</given-names></name><name><surname>Pankivskyi</surname> <given-names>S</given-names></name><name><surname>Rynditch</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Evolutionary changes on the way to clathrin-mediated endocytosis in animals</article-title><source>Genome Biology and Evolution</source><volume>8</volume><fpage>588</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1093/gbe/evw028</pub-id><pub-id pub-id-type="pmid">26872775</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname> <given-names>M</given-names></name><name><surname>Boll</surname> <given-names>W</given-names></name><name><surname>Van Oijen</surname> <given-names>A</given-names></name><name><surname>Hariharan</surname> <given-names>R</given-names></name><name><surname>Chandran</surname> <given-names>K</given-names></name><name><surname>Nibert</surname> <given-names>ML</given-names></name><name><surname>Kirchhausen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Endocytosis by random initiation and stabilization of clathrin-coated pits</article-title><source>Cell</source><volume>118</volume><fpage>591</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.08.017</pub-id><pub-id pub-id-type="pmid">15339664</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frøkjaer-Jensen</surname> <given-names>C</given-names></name><name><surname>Davis</surname> <given-names>MW</given-names></name><name><surname>Hopkins</surname> <given-names>CE</given-names></name><name><surname>Newman</surname> <given-names>BJ</given-names></name><name><surname>Thummel</surname> <given-names>JM</given-names></name><name><surname>Olesen</surname> <given-names>SP</given-names></name><name><surname>Grunnet</surname> <given-names>M</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Single-copy insertion of transgenes in <italic>Caenorhabditis elegans</italic></article-title><source>Nature Genetics</source><volume>40</volume><fpage>1375</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.1038/ng.248</pub-id><pub-id pub-id-type="pmid">18953339</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frøkjær-Jensen</surname> <given-names>C</given-names></name><name><surname>Davis</surname> <given-names>MW</given-names></name><name><surname>Ailion</surname> <given-names>M</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Improved Mos1-mediated transgenesis in <italic>C. elegans</italic></article-title><source>Nature Methods</source><volume>9</volume><fpage>117</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1865</pub-id><pub-id pub-id-type="pmid">22290181</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>P</given-names></name><name><surname>Kornfeld</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>AP-1 binding to sorting signals and release from clathrin-coated vesicles is regulated by phosphorylation</article-title><source>The Journal of Cell Biology</source><volume>160</volume><fpage>699</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1083/jcb.200211080</pub-id><pub-id pub-id-type="pmid">12604586</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname> <given-names>DG</given-names></name><name><surname>Young</surname> <given-names>L</given-names></name><name><surname>Chuang</surname> <given-names>RY</given-names></name><name><surname>Venter</surname> <given-names>JC</given-names></name><name><surname>Hutchison</surname> <given-names>CA</given-names></name><name><surname>Smith</surname> <given-names>HO</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title><source>Nature Methods</source><volume>6</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1318</pub-id><pub-id pub-id-type="pmid">19363495</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greener</surname> <given-names>T</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Nojima</surname> <given-names>H</given-names></name><name><surname>Eisenberg</surname> <given-names>E</given-names></name><name><surname>Greene</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>1365</fpage><lpage>1370</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.2.1365</pub-id><pub-id pub-id-type="pmid">10625686</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Watanabe</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Hollopeter</surname> <given-names>G</given-names></name><name><surname>Grant</surname> <given-names>BD</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>AP2 hemicomplexes contribute independently to synaptic vesicle endocytosis</article-title><source>eLife</source><volume>2</volume><elocation-id>e00190</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.00190</pub-id><pub-id pub-id-type="pmid">23482940</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname> <given-names>LA</given-names></name><name><surname>Newmyer</surname> <given-names>SL</given-names></name><name><surname>Schmid</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>ATP- and cytosol-dependent release of adaptor proteins from clathrin-coated vesicles: A dual role for Hsc70</article-title><source>Molecular Biology of the Cell</source><volume>9</volume><fpage>2217</fpage><lpage>2229</lpage><pub-id pub-id-type="doi">10.1091/mbc.9.8.2217</pub-id><pub-id pub-id-type="pmid">9693377</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henne</surname> <given-names>WM</given-names></name><name><surname>Boucrot</surname> <given-names>E</given-names></name><name><surname>Meinecke</surname> <given-names>M</given-names></name><name><surname>Evergren</surname> <given-names>E</given-names></name><name><surname>Vallis</surname> <given-names>Y</given-names></name><name><surname>Mittal</surname> <given-names>R</given-names></name><name><surname>McMahon</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>FCHo proteins are nucleators of clathrin-mediated endocytosis</article-title><source>Science</source><volume>328</volume><fpage>1281</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1126/science.1188462</pub-id><pub-id pub-id-type="pmid">20448150</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollopeter</surname> <given-names>G</given-names></name><name><surname>Lange</surname> <given-names>JJ</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Vu</surname> <given-names>TN</given-names></name><name><surname>Gu</surname> <given-names>M</given-names></name><name><surname>Ailion</surname> <given-names>M</given-names></name><name><surname>Lambie</surname> <given-names>EJ</given-names></name><name><surname>Slaughter</surname> <given-names>BD</given-names></name><name><surname>Unruh</surname> <given-names>JR</given-names></name><name><surname>Florens</surname> <given-names>L</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The membrane-associated proteins FCHo and SGIP are allosteric activators of the AP2 clathrin adaptor complex</article-title><source>eLife</source><volume>3</volume><elocation-id>e03648</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03648</pub-id><pub-id pub-id-type="pmid">25303366</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höning</surname> <given-names>S</given-names></name><name><surname>Ricotta</surname> <given-names>D</given-names></name><name><surname>Krauss</surname> <given-names>M</given-names></name><name><surname>Späte</surname> <given-names>K</given-names></name><name><surname>Spolaore</surname> <given-names>B</given-names></name><name><surname>Motley</surname> <given-names>A</given-names></name><name><surname>Robinson</surname> <given-names>M</given-names></name><name><surname>Robinson</surname> <given-names>C</given-names></name><name><surname>Haucke</surname> <given-names>V</given-names></name><name><surname>Owen</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2</article-title><source>Molecular Cell</source><volume>18</volume><fpage>519</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.04.019</pub-id><pub-id pub-id-type="pmid">15916959</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname> <given-names>AP</given-names></name><name><surname>Flett</surname> <given-names>A</given-names></name><name><surname>Smythe</surname> <given-names>C</given-names></name><name><surname>Hufton</surname> <given-names>L</given-names></name><name><surname>Wettey</surname> <given-names>FR</given-names></name><name><surname>Smythe</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Clathrin promotes incorporation of cargo into coated pits by activation of the AP2 adaptor micro2 kinase</article-title><source>The Journal of Cell Biology</source><volume>163</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1083/jcb.200304079</pub-id><pub-id pub-id-type="pmid">14581451</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname> <given-names>LP</given-names></name><name><surname>Kelly</surname> <given-names>BT</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Gaffry</surname> <given-names>T</given-names></name><name><surname>James</surname> <given-names>LC</given-names></name><name><surname>Collins</surname> <given-names>BM</given-names></name><name><surname>Höning</surname> <given-names>S</given-names></name><name><surname>Evans</surname> <given-names>PR</given-names></name><name><surname>Owen</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A large-scale conformational change couples membrane recruitment to cargo binding in the AP2 clathrin adaptor complex</article-title><source>Cell</source><volume>141</volume><fpage>1220</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.05.006</pub-id><pub-id pub-id-type="pmid">20603002</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadlecova</surname> <given-names>Z</given-names></name><name><surname>Spielman</surname> <given-names>SJ</given-names></name><name><surname>Loerke</surname> <given-names>D</given-names></name><name><surname>Mohanakrishnan</surname> <given-names>A</given-names></name><name><surname>Reed</surname> <given-names>DK</given-names></name><name><surname>Schmid</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1083/jcb.201608071</pub-id><pub-id pub-id-type="pmid">28003333</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>BT</given-names></name><name><surname>Graham</surname> <given-names>SC</given-names></name><name><surname>Liska</surname> <given-names>N</given-names></name><name><surname>Dannhauser</surname> <given-names>PN</given-names></name><name><surname>Höning</surname> <given-names>S</given-names></name><name><surname>Ungewickell</surname> <given-names>EJ</given-names></name><name><surname>Owen</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clathrin adaptors. AP2 controls clathrin polymerization with a membrane-activated switch</article-title><source>Science</source><volume>345</volume><fpage>459</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1126/science.1254836</pub-id><pub-id pub-id-type="pmid">25061211</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>BT</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Späte</surname> <given-names>K</given-names></name><name><surname>Miller</surname> <given-names>SE</given-names></name><name><surname>Evans</surname> <given-names>PR</given-names></name><name><surname>Höning</surname> <given-names>S</given-names></name><name><surname>Owen</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex</article-title><source>Nature</source><volume>456</volume><fpage>976</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1038/nature07422</pub-id><pub-id pub-id-type="pmid">19140243</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>E</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Gabel</surname> <given-names>CV</given-names></name><name><surname>Fang-Yen</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Long-term imaging of <italic>Caenorhabditis elegans</italic> using nanoparticle-mediated immobilization</article-title><source>PLoS One</source><volume>8</volume><elocation-id>e53419</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053419</pub-id><pub-id pub-id-type="pmid">23301069</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchhausen</surname> <given-names>T</given-names></name><name><surname>Owen</surname> <given-names>D</given-names></name><name><surname>Harrison</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Molecular structure, function, and dynamics of clathrin-mediated membrane traffic</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>6</volume><elocation-id>a016725</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016725</pub-id><pub-id pub-id-type="pmid">24789820</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Umasankar</surname> <given-names>PK</given-names></name><name><surname>Wrobel</surname> <given-names>AG</given-names></name><name><surname>Lymar</surname> <given-names>A</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Holkar</surname> <given-names>SS</given-names></name><name><surname>Jha</surname> <given-names>A</given-names></name><name><surname>Pradhan-Sundd</surname> <given-names>T</given-names></name><name><surname>Watkins</surname> <given-names>SC</given-names></name><name><surname>Owen</surname> <given-names>DJ</given-names></name><name><surname>Traub</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transient Fcho1/2⋅Eps15/R⋅AP-2 Nanoclusters Prime the AP-2 Clathrin Adaptor for Cargo Binding</article-title><source>Developmental Cell</source><volume>37</volume><fpage>428</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.05.003</pub-id><pub-id pub-id-type="pmid">27237791</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manna</surname> <given-names>PT</given-names></name><name><surname>Gadelha</surname> <given-names>C</given-names></name><name><surname>Puttick</surname> <given-names>AE</given-names></name><name><surname>Field</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ENTH and ANTH domain proteins participate in AP2-independent clathrin-mediated endocytosis</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>2130</fpage><lpage>2142</lpage><pub-id pub-id-type="doi">10.1242/jcs.167726</pub-id><pub-id pub-id-type="pmid">25908855</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname> <given-names>W</given-names></name><name><surname>Kirchhausen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Stabilization of clathrin coats by the core of the clathrin-associated protein complex AP-2</article-title><source>Biochemistry</source><volume>29</volume><fpage>10791</fpage><lpage>10798</lpage><pub-id pub-id-type="doi">10.1021/bi00500a011</pub-id><pub-id pub-id-type="pmid">2125494</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayers</surname> <given-names>JR</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Pramanik</surname> <given-names>J</given-names></name><name><surname>Johnson</surname> <given-names>A</given-names></name><name><surname>Sarkeshik</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Saengsawang</surname> <given-names>W</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name><name><surname>Audhya</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Regulation of ubiquitin-dependent cargo sorting by multiple endocytic adaptors at the plasma membrane</article-title><source>PNAS</source><volume>110</volume><fpage>11857</fpage><lpage>11862</lpage><pub-id pub-id-type="doi">10.1073/pnas.1302918110</pub-id><pub-id pub-id-type="pmid">23818590</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olusanya</surname> <given-names>O</given-names></name><name><surname>Andrews</surname> <given-names>PD</given-names></name><name><surname>Swedlow</surname> <given-names>JR</given-names></name><name><surname>Smythe</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Phosphorylation of threonine 156 of the mu2 subunit of the AP2 complex is essential for endocytosis <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Current Biology</source><volume>11</volume><fpage>896</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(01)00240-8</pub-id><pub-id pub-id-type="pmid">11516654</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paix</surname> <given-names>A</given-names></name><name><surname>Folkmann</surname> <given-names>A</given-names></name><name><surname>Rasoloson</surname> <given-names>D</given-names></name><name><surname>Seydoux</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>High efficiency, homology-directed genome editing in <italic>Caenorhabditis elegans</italic> using CRISPR-Cas9 ribonucleoprotein complexes</article-title><source>Genetics</source><volume>201</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.179382</pub-id><pub-id pub-id-type="pmid">26187122</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapoport</surname> <given-names>I</given-names></name><name><surname>Miyazaki</surname> <given-names>M</given-names></name><name><surname>Boll</surname> <given-names>W</given-names></name><name><surname>Duckworth</surname> <given-names>B</given-names></name><name><surname>Cantley</surname> <given-names>LC</given-names></name><name><surname>Shoelson</surname> <given-names>S</given-names></name><name><surname>Kirchhausen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Regulatory interactions in the recognition of endocytic sorting signals by AP-2 complexes</article-title><source>The EMBO Journal</source><volume>16</volume><fpage>2240</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1093/emboj/16.9.2240</pub-id><pub-id pub-id-type="pmid">9171339</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reider</surname> <given-names>A</given-names></name><name><surname>Barker</surname> <given-names>SL</given-names></name><name><surname>Mishra</surname> <given-names>SK</given-names></name><name><surname>Im</surname> <given-names>YJ</given-names></name><name><surname>Maldonado-Báez</surname> <given-names>L</given-names></name><name><surname>Hurley</surname> <given-names>JH</given-names></name><name><surname>Traub</surname> <given-names>LM</given-names></name><name><surname>Wendland</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Syp1 is a conserved endocytic adaptor that contains domains involved in cargo selection and membrane tubulation</article-title><source>The EMBO Journal</source><volume>28</volume><fpage>3103</fpage><lpage>3116</lpage><pub-id pub-id-type="doi">10.1038/emboj.2009.248</pub-id><pub-id pub-id-type="pmid">19713939</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricotta</surname> <given-names>D</given-names></name><name><surname>Conner</surname> <given-names>SD</given-names></name><name><surname>Schmid</surname> <given-names>SL</given-names></name><name><surname>von Figura</surname> <given-names>K</given-names></name><name><surname>Honing</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Phosphorylation of the AP2 mu subunit by AAK1 mediates high affinity binding to membrane protein sorting signals</article-title><source>The Journal of Cell Biology</source><volume>156</volume><fpage>791</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1083/jcb.200111068</pub-id><pub-id pub-id-type="pmid">11877457</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname> <given-names>B</given-names></name><name><surname>Denisov</surname> <given-names>AY</given-names></name><name><surname>Philie</surname> <given-names>J</given-names></name><name><surname>Allaire</surname> <given-names>PD</given-names></name><name><surname>Legendre-Guillemin</surname> <given-names>V</given-names></name><name><surname>Zylbergold</surname> <given-names>P</given-names></name><name><surname>Gehring</surname> <given-names>K</given-names></name><name><surname>McPherson</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The NECAP PHear domain increases clathrin accessory protein binding potential</article-title><source>The EMBO Journal</source><volume>26</volume><fpage>4066</fpage><lpage>4077</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601836</pub-id><pub-id pub-id-type="pmid">17762867</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname> <given-names>B</given-names></name><name><surname>Denisov</surname> <given-names>AY</given-names></name><name><surname>Philie</surname> <given-names>J</given-names></name><name><surname>Deprez</surname> <given-names>C</given-names></name><name><surname>Tung</surname> <given-names>EC</given-names></name><name><surname>Gehring</surname> <given-names>K</given-names></name><name><surname>McPherson</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Two WXXF-based motifs in NECAPs define the specificity of accessory protein binding to AP-1 and AP-2</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>3701</fpage><lpage>3710</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600378</pub-id><pub-id pub-id-type="pmid">15359277</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname> <given-names>B</given-names></name><name><surname>Murphy</surname> <given-names>S</given-names></name><name><surname>Dokainish</surname> <given-names>H</given-names></name><name><surname>Girard</surname> <given-names>M</given-names></name><name><surname>Gudheti</surname> <given-names>MV</given-names></name><name><surname>Kozlov</surname> <given-names>G</given-names></name><name><surname>Halin</surname> <given-names>M</given-names></name><name><surname>Philie</surname> <given-names>J</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name><name><surname>Gehring</surname> <given-names>K</given-names></name><name><surname>McPherson</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>NECAP 1 regulates AP-2 interactions to control vesicle size, number, and cargo during clathrin-mediated endocytosis</article-title><source>PLoS Biology</source><volume>11</volume><elocation-id>e1001670</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001670</pub-id><pub-id pub-id-type="pmid">24130457</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname> <given-names>B</given-names></name><name><surname>Philie</surname> <given-names>J</given-names></name><name><surname>Girard</surname> <given-names>M</given-names></name><name><surname>Tung</surname> <given-names>EC</given-names></name><name><surname>Blondeau</surname> <given-names>F</given-names></name><name><surname>McPherson</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Identification of a family of endocytic proteins that define a new alpha-adaptin ear-binding motif</article-title><source>EMBO Reports</source><volume>4</volume><fpage>1089</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.7400004</pub-id><pub-id pub-id-type="pmid">14555962</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaushi</surname> <given-names>S</given-names></name><name><surname>Inoue</surname> <given-names>K</given-names></name><name><surname>Zushi</surname> <given-names>H</given-names></name><name><surname>Senda-Murata</surname> <given-names>K</given-names></name><name><surname>Fukada</surname> <given-names>T</given-names></name><name><surname>Oka</surname> <given-names>S</given-names></name><name><surname>Sugimoto</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dynamic behavior of FCHO1 revealed by live-cell imaging microscopy: its possible involvement in clathrin-coated vesicle formation</article-title><source>Bioscience, Biotechnology, and Biochemistry</source><volume>71</volume><fpage>1764</fpage><lpage>1768</lpage><pub-id pub-id-type="doi">10.1271/bbb.60720</pub-id><pub-id pub-id-type="pmid">17617719</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>K</given-names></name><name><surname>Norris</surname> <given-names>A</given-names></name><name><surname>Sato</surname> <given-names>M</given-names></name><name><surname>Grant</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>C. elegans</italic> as a model for membrane traffic</article-title><source>WormBook</source><volume>47</volume><fpage>1</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1895/wormbook.1.77.2</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semerdjieva</surname> <given-names>S</given-names></name><name><surname>Shortt</surname> <given-names>B</given-names></name><name><surname>Maxwell</surname> <given-names>E</given-names></name><name><surname>Singh</surname> <given-names>S</given-names></name><name><surname>Fonarev</surname> <given-names>P</given-names></name><name><surname>Hansen</surname> <given-names>J</given-names></name><name><surname>Schiavo</surname> <given-names>G</given-names></name><name><surname>Grant</surname> <given-names>BD</given-names></name><name><surname>Smythe</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Coordinated regulation of AP2 uncoating from clathrin-coated vesicles by rab5 and hRME-6</article-title><source>The Journal of Cell Biology</source><volume>183</volume><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1083/jcb.200806016</pub-id><pub-id pub-id-type="pmid">18981233</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sochacki</surname> <given-names>KA</given-names></name><name><surname>Dickey</surname> <given-names>AM</given-names></name><name><surname>Strub</surname> <given-names>MP</given-names></name><name><surname>Taraska</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endocytic proteins are partitioned at the edge of the clathrin lattice in mammalian cells</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>352</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/ncb3498</pub-id><pub-id pub-id-type="pmid">28346440</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>MJ</given-names></name><name><surname>Perrais</surname> <given-names>D</given-names></name><name><surname>Merrifield</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis</article-title><source>PLoS Biology</source><volume>9</volume><elocation-id>e1000604</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000604</pub-id><pub-id pub-id-type="pmid">21445324</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezu</surname> <given-names>A</given-names></name><name><surname>Horiuchi</surname> <given-names>A</given-names></name><name><surname>Kanda</surname> <given-names>K</given-names></name><name><surname>Kikuchi</surname> <given-names>N</given-names></name><name><surname>Umeda</surname> <given-names>K</given-names></name><name><surname>Tsujita</surname> <given-names>K</given-names></name><name><surname>Suetsugu</surname> <given-names>S</given-names></name><name><surname>Araki</surname> <given-names>N</given-names></name><name><surname>Yamamoto</surname> <given-names>H</given-names></name><name><surname>Takenawa</surname> <given-names>T</given-names></name><name><surname>Nakanishi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SGIP1alpha is an endocytic protein that directly interacts with phospholipids and Eps15</article-title><source>Journal of Biological Chemistry</source><volume>282</volume><fpage>26481</fpage><lpage>26489</lpage><pub-id pub-id-type="doi">10.1074/jbc.M703815200</pub-id><pub-id pub-id-type="pmid">17626015</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umasankar</surname> <given-names>PK</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Thieman</surname> <given-names>JR</given-names></name><name><surname>Jha</surname> <given-names>A</given-names></name><name><surname>Doray</surname> <given-names>B</given-names></name><name><surname>Watkins</surname> <given-names>SC</given-names></name><name><surname>Traub</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A clathrin coat assembly role for the muniscin protein central linker revealed by TALEN-mediated gene editing</article-title><source>eLife</source><volume>3</volume><elocation-id>e04137</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.04137</pub-id><pub-id pub-id-type="pmid">25303365</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umeda</surname> <given-names>A</given-names></name><name><surname>Meyerholz</surname> <given-names>A</given-names></name><name><surname>Ungewickell</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Identification of the universal cofactor (auxilin 2) in clathrin coat dissociation</article-title><source>European Journal of Cell Biology</source><volume>79</volume><fpage>336</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1078/S0171-9335(04)70037-0</pub-id><pub-id pub-id-type="pmid">10887964</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ungewickell</surname> <given-names>E</given-names></name><name><surname>Ungewickell</surname> <given-names>H</given-names></name><name><surname>Holstein</surname> <given-names>SE</given-names></name><name><surname>Lindner</surname> <given-names>R</given-names></name><name><surname>Prasad</surname> <given-names>K</given-names></name><name><surname>Barouch</surname> <given-names>W</given-names></name><name><surname>Martin</surname> <given-names>B</given-names></name><name><surname>Greene</surname> <given-names>LE</given-names></name><name><surname>Eisenberg</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Role of auxilin in uncoating clathrin-coated vesicles</article-title><source>Nature</source><volume>378</volume><fpage>632</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/378632a0</pub-id><pub-id pub-id-type="pmid">8524399</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Johnson</surname> <given-names>A</given-names></name><name><surname>Hanna</surname> <given-names>M</given-names></name><name><surname>Audhya</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Eps15 membrane-binding and -bending activity acts redundantly with Fcho1 during clathrin-mediated endocytosis</article-title><source>Molecular Biology of the Cell</source><volume>27</volume><fpage>2675</fpage><lpage>2687</lpage><pub-id pub-id-type="doi">10.1091/mbc.E16-03-0151</pub-id><pub-id pub-id-type="pmid">27385343</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasiak</surname> <given-names>S</given-names></name><name><surname>Legendre-Guillemin</surname> <given-names>V</given-names></name><name><surname>Puertollano</surname> <given-names>R</given-names></name><name><surname>Blondeau</surname> <given-names>F</given-names></name><name><surname>Girard</surname> <given-names>M</given-names></name><name><surname>de Heuvel</surname> <given-names>E</given-names></name><name><surname>Boismenu</surname> <given-names>D</given-names></name><name><surname>Bell</surname> <given-names>AW</given-names></name><name><surname>Bonifacino</surname> <given-names>JS</given-names></name><name><surname>McPherson</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Enthoprotin: a novel clathrin-associated protein identified through subcellular proteomics</article-title><source>The Journal of Cell Biology</source><volume>158</volume><fpage>855</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1083/jcb.200205078</pub-id><pub-id pub-id-type="pmid">12213833</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>JG</given-names></name><name><surname>Southgate</surname> <given-names>E</given-names></name><name><surname>Thomson</surname> <given-names>JN</given-names></name><name><surname>Brenner</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>The structure of the nervous system of the nematode <italic>Caenorhabditis elegans</italic></article-title><source>Philosophical Transactions of the Royal Society B: Biological Sciences</source><volume>314</volume><fpage>1</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1098/rstb.1986.0056</pub-id><pub-id pub-id-type="pmid">22462104</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.32242.015</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Reviewing Editor</role><aff id="aff4"><institution>Stanford University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;NECAPs are negative regulators of the AP2 clathrin adaptor complex&quot; for consideration by <italic>eLife</italic>. Your article has been favorably evaluated by Vivek Malhotra (Senior Editor) and three reviewers, one of whom, Suzanne Pfeffer, is a member of our Board of Reviewing Editors. The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>NECAP1 has been shown by McPherson and colleagues (2013) to regulate AP-2:clathrin interactions, thereby controlling endocytic vesicle size, number and cargo during endocytosis in fibroblasts and cultured hippocampal neurons. It does this by modulating accessory protein binding to AP-2 in coordination with clathrin binding. Here, the authors identify ncap-1 as a suppressor of fcho-1 mutants in <italic>C. elegans</italic>. Loss of NCAP-1 restores AP2 activity in fcho-1 mutants; Ce and murine NCAP-1 or 2 can rescue. The authors show that NECAPs bind open and phosphorylated AP2 core and seem to stabilize the phosphoform in vivo, thereby regulating its activity. These genetic data complement those previously reported from the McPherson group and extend our understanding of how various NECAP complexes may regulate clathrin function.</p><p>Overall, the reviewers thought the data were high quality and suggest the following experiments to bring the story to the level of impact that will make it suitable for presentation in <italic>eLife</italic>.</p><p>1) Do the nature of some of the NECAP point mutants isolated provide any insight into a mechanism by which loss of AP2 regulatory function may occur? For example, do the A29D or S84N prevent interaction between NECAP and AP-2 (either the open conformation or the phosphorylated complex)? Or do these mutations simply affect stability of NECAP? Investigating this idea further may reveal key insights into the specific role of NECAP proteins in modulating AP2 activity.</p><p>2) Please include some quantification of the data shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p>3) The model presented seems rather oversimplified. How precisely do the authors envision that loss of NECAP bypasses FCHO? In FCHO mutant animals, AP2 remains largely closed and hypo-phosphorylated, based on the authors' previous work. Since NECAP proteins fail to bind AP2 under these conditions, it is unclear how bypass is achieved in the absence of FCHO. The authors do not clarify this issue in the Discussion, but this should really be directly addressed.</p><p>4) In <xref ref-type="fig" rid="fig5">Figure 5</xref>, the authors analyze the effects of AP-2 activating mutations on relative enrichment of NECAP and AP-2 in nerve rings. This follows data in <xref ref-type="fig" rid="fig4">Figure 4</xref> that, in vitro, NECAP binds poorly to the closed form of AP-2 core. Considering the in vitro data, a reader might expect that the ratio of NECAP to AP-2 in fcho1 mutants would be lower than wild-type since AP-2 in fcho1 animals is more closed than wild-type. Consequently, in describing the results in the subsection “NCAP-1 localizes with constitutively open AP2 in vivo”, the authors might want to explain why the ratios in wild-type and fcho1 mutants are the same (perhaps because of NECAP binding to AP-2 appendages?).</p><p>5) The Ritter papers should be more explicitly described in the Introduction. Also, if there was any way to link the papers – i.e., incorporate the previous finding into a new <xref ref-type="fig" rid="fig6">Figure 6</xref> model, it would help the non-Fcho experts understand this solid advance.</p><p>6) Figure legends should be clarified so that they can be read independent of the manuscript text. <xref ref-type="fig" rid="fig6">Figure 6</xref> legend is very unclear for non-experts. For example, Fig, 2E phosphorylation assay [of what?].</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;NECAPs are negative regulators of the AP2 clathrin adaptor complex&quot; for further consideration at <italic>eLife</italic>. Your revised article has been favorably evaluated by Vivek Malhotra (Senior Editor), a Reviewing Editor, and two reviewers.</p><p>The reviewers felt you have done a very good job addressing their concerns. One reviewer noted that just for clarity, you might want to address the apparent discrepancy between the in vitro binding of mouse NECAP2 to E302K AP-2 cores in <xref ref-type="fig" rid="fig6">Figure 6B</xref> and the absence of recruitment of <italic>C. elegans</italic> NCAP-1 to nerve rings in the corresponding E306K AP-2 worm mutant. Perhaps at the end of the subsection” Missense mutations render NECAPs functionally inactive”, you could include something like, &quot;In contrast to these in vitro results, the absence of NCAP-1 recruitment to nerve rings in the E302K <italic>C. elegans</italic> mutant is presumably due to phosphorylation of this mutant in vivo&quot;.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.32242.016</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>[…] Overall, the reviewers thought the data were high quality and suggest the following experiments to bring the story to the level of impact that will make it suitable for presentation in eLife.</p><p>1) Do the nature of some of the NECAP point mutants isolated provide any insight into a mechanism by which loss of AP2 regulatory function may occur? For example, do the A29D or S84N prevent interaction between NECAP and AP-2 (either the open conformation or the phosphorylated complex)? Or do these mutations simply affect stability of NECAP? Investigating this idea further may reveal key insights into the specific role of NECAP proteins in modulating AP2 activity.</p></disp-quote><p>The reviewers astutely recognized that further analysis of the special missense mutations in NCAP-1 isolated as bypass suppressors of fcho-1 mutants would yield mechanistic insight into how NECAPs negatively regulate AP2. We employed a multipronged approach to these experiments. First, we engineered the A29D and S84N mutations into worms expressing a single copy RFP:NCAP-1 transgene using CRISPR. We then evaluated the effect of these mutations on NCAP-1 stability and activity using our in vivo assays. Even though these mutant forms of NCAP-1 are stable according to western blot analysis, they fail to complement <italic>ncap-1</italic> mutants or restore the closed form of AP2 in <italic>fcho-1</italic> mutants, and do not associate with open, hyper-phosphorylated AP2 in vivo. Because these residues are highly conserved, we also introduced the equivalent mutations into vertebrate NECAP2 proteins and verified that they produced stable recombinant proteins. Interestingly, when these mutated NECAP2 proteins were used as bait in in vitro pulldown assays, they appeared to have selectively lost the ability to bind to the phosphorylated AP2 core. We interpret these results as further support of our model that the conserved N-terminal region of NECAPs known as the PHear domain negatively regulates the AP2 complex by directly binding the phosphorylated core. The data have been assembled into a new <xref ref-type="fig" rid="fig6">Figure 6</xref> along with the <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref> and described in the Results and Discussion.</p><p>Results: “In the <italic>fcho-1</italic> suppressor screen, we isolated two independent missense mutations in the N-terminal PHear domain of NCAP-1: A29D and S84N (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). […] These data indicate that the missense mutations in NCAP-1 obstruct AP2 inactivation by preventing NCAP-1 from binding to the phosphorylated AP2 core.”</p><p>Discussion: “Based on the missense mutations that disrupt NECAP activity in vivo and AP2 binding in vitro (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), we believe this inhibitory function may involve a direct interaction of the N-terminal PHear domain (Ritter et al., 2007) with the phosphorylated AP2 core.”</p><p>We also evaluated a third missense NCAP-1 mutation (E108V) using the same approaches and determined that this mutant exhibited wild-type activity in our assays. One obvious explanation for this discrepancy is that there are additional mutations in the strain we isolated from our mutagenesis screen that are partially or entirely responsible for the suppression of <italic>fcho-1</italic>. Thus, we have decided to remove this confusing NCAP-1 mutant from the list of alleles that suppress fcho-1 until we further delineate the mutations responsible for the suppression we observe in the original strain.</p><disp-quote content-type="editor-comment"><p>2) Please include some quantification of the data shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p>The data in <xref ref-type="fig" rid="fig4">Figure 4</xref> represents stained protein gels or western blot analysis of AP2 complexes isolated from pulldown assays using NECAP proteins as the bait. We have quantified the intensity of the AP2 α subunit in each pulldown, normalized to a negative control (HaloTag alone) and included these values in <xref ref-type="fig" rid="fig4">Figure 4</xref>. We also performed this analysis for the pulldowns performed in response to Point 1 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>).</p><p>3) The model presented seems rather oversimplified. How precisely do the authors envision that loss of NECAP bypasses FCHO? In FCHO mutant animals, AP2 remains largely closed and hypo-phosphorylated, based on the authors' previous work. Since NECAP proteins fail to bind AP2 under these conditions, it is unclear how bypass is achieved in the absence of FCHO. The authors do not clarify this issue in the Discussion, but this should really be directly addressed.</p></disp-quote><p>We appreciate this feedback and recognize that this point needed clarification in the Discussion. Essentially, we propose that in the absence of NCAP-1, the lifetime of the open state is increased. We hypothesize that without allosteric activation by FCHO-1, AP2 still attains the open, phosphorylated state, albeit at a reduced rate. In this context (<italic>fcho-1</italic> mutants), NCAP-1 inactivates these AP2 complexes, causing the closed, inactive form of AP2 to predominate in <italic>fcho-1</italic> mutants. Removal of NCAP-1 tips the balance toward maintaining the open, active AP2 conformation. The <italic>fcho-1</italic> suppressor screen appears to have yielded three potential routes to escape inactivation by NCAP-1 that enable AP2 to accumulate in more active, if unregulated forms: 1) open AP2 mutations that constitutively bind NCAP-1 but resist its action, 2) phosphorylation site mutations in AP2 that evade NCAP-1 binding and 3) mutations in the <italic>ncap-1</italic> gene itself that produce a defective protein. We have clarified our model in the Discussion and in our new model figure (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><p>Discussion: “…mutations that directly disrupt NCAP-1 (class 3) probably enable a basal level of AP2 activity to be sustained by complexes that succeed in attaining the open, phosphorylated state in lieu of allosteric activation by muniscins.”</p><p><xref ref-type="fig" rid="fig7">Figure 7</xref> legend: “In the absence of muniscins, AP2 activation is greatly reduced. The <italic>fcho-1</italic> suppressor screen isolated three classes of mutations that enable AP2 to remain active in lieu of muniscins…”</p><disp-quote content-type="editor-comment"><p>4) In <xref ref-type="fig" rid="fig5">Figure 5</xref>, the authors analyze the effects of AP-2 activating mutations on relative enrichment of NECAP and AP-2 in nerve rings. This follows data in <xref ref-type="fig" rid="fig4">Figure 4</xref> that, in vitro, NECAP binds poorly to the closed form of AP-2 core. Considering the in vitro data, a reader might expect that the ratio of NECAP to AP-2 in fcho1 mutants would be lower than wild-type since AP-2 in fcho1 animals is more closed than wild-type. Consequently, in describing the results in the subsection “NCAP-1 localizes with constitutively open AP2 in vivo”, the authors might want to explain why the ratios in wild-type and fcho1 mutants are the same (perhaps because of NECAP binding to AP-2 appendages?).</p></disp-quote><p>We agree that the lack of difference between wild type and fcho-1 mutants is confusing at first glance. We interpret this as support of the model that worm NECAP (NCAP-1) is not usually coincident with AP2 on the membrane. In data not included in this manuscript, we failed to observe co-localization of RFP:NCAP-1 with AP2 on the plasma membrane of coelomocytes. Instead, we believe that open AP2 mutants <italic>artificially</italic> recruit NCAP-1 to sites of endocytosis and that this effect is most striking at the nerve ring, a tissue rich in membrane and synapses. However, we have not observed a similar enrichment on the membrane of coelomocytes. The limited resolution of our microscopy, coupled with the small diameter of the neuronal processes in the nerve ring, does not allow us to discern whether NCAP-1 and AP2 are truly co-localized on the membrane. We have included statements regarding our interpretation of the microscopy data in the Results and Discussion.</p><p>Results: “In both wild type and <italic>fcho-1</italic> mutant worms, NCAP-1 was not overtly enriched compared to AP2. The low level of NCAP-1 relative to AP2 may indicate that in worms, NCAP-1 is not stably associated with AP2 on membranes.”</p><p>Results: “In other words, NCAP-1 was abnormally recruited to the nerve ring in the open AP2 mutant…”</p><p>Discussion: “Open, hyper-phosphorylated AP2 mutants (class 1) appear to recruit NECAPs in excess…”</p><p>It is worth noting that NCAP-1 lacks the consensus C-terminal α appendage-binding motif (WXXF) and instead ends with LLDF, so we are not confident NCAP-1 binds the α appendage of AP2 in <italic>C. elegans</italic>. Nevertheless, it is possible the low levels of RFP:NCAP-1 we observe in worms with and without <italic>fcho-1</italic> may represent NCAP-1 bound to the AP2 appendages and we have included this as a possible explanation in the Results.</p><p>Results: “It is possible that the basal level of localization observed in both wild type and <italic>fcho-1</italic> mutants may represent NCAP-1 bound to the AP2 appendages (Ritter et al., 2013; Ritter et al., 2003).”</p><disp-quote content-type="editor-comment"><p>5) The Ritter papers should be more explicitly described in the Introduction. Also, if there was any way to link the papers – i.e., incorporate the previous finding into a new <xref ref-type="fig" rid="fig6">Figure 6</xref> model, it would help the non-Fcho experts understand this solid advance.</p></disp-quote><p>We have expanded the summary of previous work on NECAPs in the introduction to include more of the discoveries of Ritter and colleagues.</p><p>Introduction: “NECAPs were originally identified as endocytic accessory proteins through proteomic analysis of clathrin-coated vesicles (Wasiak et al., 2002) and were shown to bind the AP2 α appendage via a C-terminal WXXF motif (Ritter et al., 2004; Ritter et al., 2003). […] By contrast, ubiquitously-expressed NECAP2 has been proposed to recruit a different clathrin adaptor, AP1, to early endosomes to facilitate fast recycling of receptors back to the cell surface (Chamberland, Antonow, Dias Santos, and Ritter, 2016).”</p><p>We have constructed a new model figure (now <xref ref-type="fig" rid="fig7">Figure 7</xref>, see legend below) that synthesizes the previous work and incorporates our new findings using language we hope will be more accessible to readers unfamiliar with FCHo proteins. We have also linked the results in this current manuscript with the previous findings in the Discussion.</p><p>Discussion: “We now recognize that these <italic>fcho-1</italic> suppressors occur in three distinct classes: dominant missense mutations that disrupt the closed conformation of AP2 (class 1) or mutate the phosphorylation site on µ2 (class 2), and recessive mutations that inactivate NCAP-1 (class 3) (<xref ref-type="fig" rid="fig7">Figure 7</xref>). […] The wealth of mutations in AP2 and NECAP identified in the <italic>fcho-1</italic> suppressor screen, combined with our biochemical and imaging data, reveal discrete steps of AP2 conformational and phosphorylation changes during its recycling (<xref ref-type="fig" rid="fig7">Figure 7</xref>).”</p><p>Discussion: “Despite this proposed divergence, both vertebrate NECAPs rescue loss of NCAP-1 in the nematode, as does a fungal NECAP that lacks the C-terminal α adaptin-ear binding WXXF motif. These results indicate that the capacity to negatively regulate AP2 has been conserved among NECAPs.”</p><disp-quote content-type="editor-comment"><p>6) Figure legends should be clarified so that they can be read independent of the manuscript text. <xref ref-type="fig" rid="fig6">Figure 6</xref> legend is very unclear for non-experts. For example, Fig, 2E phosphorylation assay [of what?].</p></disp-quote><p>We thank the reviewers for helping us to improve the clarity of our manuscript and have modified the figure legends to be clearer. The following two examples specifically address the reviewers’ suggestions:</p><p><xref ref-type="fig" rid="fig7">Figure 7</xref> (formerly <xref ref-type="fig" rid="fig6">Figure 6</xref>): “Muniscins allosterically activate AP2 to form a stable association with the membrane. […] Each class disrupts the AP2 inactivation pathway and promotes accumulation of AP2 at discrete steps in the cycle (gray arrows).”</p><p><xref ref-type="fig" rid="fig2">Figure 2</xref>: We specified that both the phosphorylation and protease sensitivity assays are of “μ2”.</p><p>[Editors' note: further revisions were requested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The reviewers felt you have done a very good job addressing their concerns. One reviewer noted that just for clarity, you might want to address the apparent discrepancy between the in vitro binding of mouse NECAP2 to E302K AP-2 cores in <xref ref-type="fig" rid="fig6">Figure 6B</xref> and the absence of recruitment of C. elegans NCAP-1 to nerve rings in the corresponding E306K AP-2 worm mutant. Perhaps at the end of the subsection” Missense mutations render NECAPs functionally inactive”, you could include something like, &quot;In contrast to these in vitro results, the absence of NCAP-1 recruitment to nerve rings in the E302K C. elegans mutant is presumably due to phosphorylation of this mutant in vivo&quot;.</p></disp-quote><p>We recognize that our summary of the results was unclear and insufficient. We have added a sentence of clarification at the end of the subsection “Missense mutations render NECAPs functionally inactive”:</p><p>Results – “The in vitro pulldown assays suggest that the primary reason the NCAP-1 missense mutants are inefficiently recruited to the nerve ring by the open AP2 mutation in vivo may be that the corresponding adaptor complexes are also phosphorylated.”</p><p>We also address the discrepancy in the Discussion:</p><p>Discussion – “However, an interaction with these constitutively open, non-phosphorylated cores in vitro may not be relevant; functionally inactive NECAPs (the A29D and S84N mutants) appear to bind these cores in vitro(<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>), but do not associate with the equivalent, albeit hyper-phosphorylated, open AP2 mutation in vivo (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). The non-phosphorylated open AP2 core may not be a physiological state of AP2 and might not accurately simulate the in vivo interaction between NECAP and AP2.”</p></body></sub-article></article>